Quarterlytics / Technology / Software - Infrastructure / VirnetX Holding Corp

VirnetX Holding Corp

vhc · NASDAQ Technology
Claim this profile
Ticker vhc
Exchange NASDAQ
Sector Technology
Industry Software - Infrastructure
Employees 23
← All annual reports
FY2021 Annual Report · VirnetX Holding Corp
Sign in to download
Loading PDF…
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

or

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to                   

Commission File Number: 001-33852

VirnetX Holding Corporation

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)

77-0390628
(I.R.S. Employer Identification No.)

308 Dorla Court, Suite 206
Zephyr Cove, Nevada
(Address of principal executive offices)

89448
(Zip Code)

Registrant’s telephone number, including area code: 775-548-1785
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Common Stock, par value $0.0001 per share

Trading Symbol(s)
VHC

Name of each exchange on which
registered
NYSE

Securities registered pursuant to section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☒ No  ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an
emerging  growth  company.  See  the  definitions  of  “large  accelerated  filer,”  “accelerated  filer,”  “smaller  reporting  company,”  and  “emerging  growth
company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐
Emerging growth company  ☐

Accelerated filer ☒
Smaller reporting company ☐

Non-accelerated filer ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any

new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal
control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared
or issued its audit report. ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2021, was $268,027,097
based upon the closing price of the common shares of the registrant on June 30, 2021. This calculation does not reflect a determination that certain persons
are affiliates of the registrant for any other purpose.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

71,232,856 shares of the registrant’s Common Stock were outstanding as of March 11, 2022.

 
 
 
 
 
 
 
 
 
DOCUMENTS INCORPORATED BY REFERENCE

The information required by Part III of this Annual Report on Form 10-K, to the extent not set forth herein, is incorporated by reference from the
registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2021 relating to
the registrant’s 2022 Annual Meeting of Stockholders.

 
Index

Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.

Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.

Item 10.
Item 11.
Item 12.
Item 13.
Item 14.

Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosure

INDEX

PART I

PART II

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
[Reserved]
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures about Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

PART III

Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accountant Fees and Services

Item 15.

Exhibits and Financial Statement Schedules

PART IV

1

Page

3
8
22
22
22
22

22
24
24
28
29
48
48
48
48

49
49
49
49
49

50

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

We have included or incorporated by reference in this Annual Report on Form 10-K (this “Report”), and from time to time we may make statements that
may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and
Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are based upon our current
expectations,  estimates,  assumptions,  and  beliefs  concerning  future  events  and  conditions  and  may  discuss,  among  other  things,  anticipated  future
performance  (including  sales  and  earnings),  expected  growth,  future  business  plans  and  costs  and  the  impact  of  potential  and  ongoing  litigation.  Any
statement  that  is  not  historical  in  nature  is  a  forward-looking  statement  and  may  be  identified  by  the  use  of  words  and  phrases  such  as  “anticipates,”
“believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will be,” “will continue,” “will likely result in,” and similar expressions.
These statements include our beliefs and statements regarding general industry and market conditions and growth rates, as well as general domestic and
international  economic  conditions.  Readers  are  cautioned  not  to  place  undue  reliance  on  forward-looking  statements.  Forward-looking  statements  are
necessarily subject to risks, uncertainties, and other factors, many of which are outside our control, which could cause actual results to differ materially
from  such  statements  and  from  our  historical  results  and  experience.  These  risks,  uncertainties  and  other  factors  include,  but  are  not  limited  to  those
described in Item 1A - Risk Factors of this Report and elsewhere in this Report and those described from time to time in our future reports filed with the
Securities and Exchange Commission (the “SEC”). Readers are cautioned that it is not possible to predict or identify all the risks, uncertainties and other
factors that may affect future results and that the risks described herein should not be considered a complete list. Any forward-looking statement speaks
only as of the date on which such statement is made, and we undertake no obligation to update or revise any forward-looking statement, whether as a
result of new information, future events or otherwise.

Among others, the forward-looking statements appearing in this Report that may not occur include statements that:

•

In  the  VirnetX  Inc.  v.  Apple,  Inc.  (Case  Nos.  6:11-cv-00563-RWS,  6:12-cv-00855-RWS)  (“Apple  II”)  litigation,  the  United  States  Court  of
Appeals  for  the  Federal  Circuit  (the  “Federal  Circuit”)  in  November  2019,  affirmed-in-part,  and  reversed-in-part  the  judgment  issued  by  the
United States District Court for the Eastern District of Texas (the “district court”) in the case awarding VirnetX damages of $595.9 million. On
October 30, 2020, after a trial in the district court, a jury returned a verdict in favor of VirnetX, awarding VirnetX over $502 million in damages.
On January 15, 2021, the district court denied Apple’s motion for judgment as a matter of law and affirmed the jury findings. This may imply that
VirnetX may soon receive over $500 million in cash, however, Apple has appealed to the Federal Circuit with regards to the judgement from the
district court and this appeal is awaiting calendaring for oral arguments. In addition, the patents in this case are being challenged in the United
States  Patent  and  Trademark  Office.  If  those  challenges  are  successful,  the  award  in  the  case  may  be  reduced,  eliminated  and/or delayed for a
lengthy period. The continuation of this litigation is distracting to our management, expensive, and these distractions and expenses may continue.

• We have undertaken activities to commercialize our products and patent portfolio in and outside the United States. These statements may imply
that  the  worldwide  market  for  our  commercialized  products  is  large  and  will  result  in  significant  future  revenues  for  us.  However,
commercialization of products such as ours is subject to significant obstacles and risks, including but not limited to a perception by some potential
partners and customers that they should await the outcome of the Apple II litigation before entering or considering to enter any agreement with us,
and that or other factors may lead us to be unsuccessful in obtaining further licensing agreements or making arrangements or entering contracts
which create significant future revenues for us.

EXCEPT  AS  REQUIRED  BY  LAW,  WE  UNDERTAKE  NO  OBLIGATION  TO  UPDATE  OR  REVISE  ANY  FORWARD-LOOKING
STATEMENT AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE.

2

 
 
 
 
Index

Item 1.

Business

The Company

PART I

We are an Internet security software and technology company with patented technology for various types of secure network communications, including 5G
and 4G LTE network security. Our patented Secure Domain Names and GABRIEL Connection Technology™, are the foundation for our new VirnetX One
platform  that  protects  communications  using  Zero  Trust  Network  Access  (“ZTNA”).  Our  technology  generates  secure  connections  on  a  “zero-click”  or
“single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter
any  encryption  information.  Our  portfolio  of  intellectual  property  is  the  foundation  of  our  business  model.  We  currently  own  approximately  205  total
patents  and  pending  applications,  including  72  U.S.  patents/patent  applications  and  133  foreign  patents/validations/pending  applications.  Our  patent
portfolio is primarily focused on securing real-time communications over the Internet, and related services, and is used in all our technology and products,
some of which were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., or Leidos, (f/k/a Science Applications International
Corporation, or SAIC) in 2006.

Our product portfolio includes sophisticated technologies, products and services that are available for sale worldwide. On March 1, 2022, we launched War
Room™ software, the first product on our next-generation, VirnetX One platform. This new platform builds upon our patented Secure Domain Names and
GABRIEL Connection Technology™ to further enhance the security and efficiency of our patented secure communication links. Our VirnetX One platform
is a security-as-a-service platform that protects enterprise applications, services, and infrastructure from cyber-attacks.

Our  new  War  Room™  software  product  provides  an  industry  leading,  safe,  and  secure  video  conferencing  meeting  environment  where  sensitive
communications and data is invisible to those not authorized to view it. War Room™ validates permissions of all the users, and devices requesting access
to any secure meeting room prior to granting access. We believe our War Room™ will be an attractive solution for government agencies  as  well  as  all
professional sectors such as legal, financial, and medical where limiting access to confidential data is a critical requirement.

Our  GABRIEL  Collaboration  Suite™  is  a  set  of  communication  applications  and  tools  that  use  our  GABRIEL  Secure  Communication  Platform™.  It
enables  seamless  and  secure  cross  platform  communications  between  devices  that  are  enrolled  in  our  “VIRNETX  SECURED”  network  and  have  our
software  installed.  Our  GABRIEL  Collaboration  Suite™  is  available  for  download  and  free  trial,  for  Android,  iOS,  Windows,  Linux,  and  Mac  OS  X
platforms, at https://virnetx.com.

We have an ongoing licensing program under which we offer licenses to a portion of our patent portfolio, technology, and software, including our secure
domain  name  registry  service,  to  domain  infrastructure  providers,  communication  service  providers  as  well  as  to  system  integrators.  Our  GABRIEL
Connection  Technology™  License  is  offered  to  original  equipment  manufacturer  (“OEM”)  customers  who  want  to  adopt  the  GABRIEL  Connection
Technology™  as  their  solution  for  establishing  secure  connections  using  secure  domain  names  within  their  products.  We  have  developed  GABRIEL
Connection Technology™ Software Development Kit (“SDK”) to assist with rapid integration of these techniques into existing software implementations.
Customers who want to develop their own implementation of the VirnetX patented techniques for supporting secure domain names, or other techniques
that are covered by our patent portfolio for establishing secure communication links, can purchase a patent license. The number of patents licensed, and
therefore the cost of the patent license to the customer, will depend upon which of the patents are used in a particular product or service. These licenses will
typically include an initial license fee, as well as an ongoing royalty.

We expect to continue to launch new and enhanced security platforms, software products, and services based on our GABRIEL Connection Technology™.
We will provide updates to new and existing customers as they are released to the public. Many small and medium businesses have installed our software
products in their corporate networks. We intend to continue to expand our customer base with targeted promotions and direct sales initiatives.

Our  employees  include  the  core  development  team  behind  our  patent  portfolio,  technology,  and  software.  Some  members  of  this  team  have  worked
together for over twenty years and were on same team that invented and developed this technology while working at Leidos. The team has continued its
research and development work and expanded the set of patents we acquired in 2006 from Leidos, into a larger patent portfolio. This portfolio now serves
as the foundation of our products, services, and our licensing business. It is expected to generate most of our future revenue in license fees and royalties.
We intend to continue our efforts to develop new products and technologies and further strengthen and expand our patent portfolio. We intend to continue
using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to
early licensing targets or asserting our rights for use of our patents.

Industry Overview & Trends

We believe that the rapid growth in remote work has accelerated digital business transformation initiatives that would have taken years, into a matter of
months. The demand to work remotely, explosive growth of video conferencing tools and rapid growth in the cloud has created an opportunity to secure
communications regardless of a user’s location, network, or BYOD (bring your own device).

3

 
 
 
 
 
 
 
 
 
 
 
Index

The shift to remote work and expansion of the enterprise network perimeter has driven the growth of ZTNA solutions. The Zero Trust concept treats all
networks like the Internet, where all users and devices are untrusted by default. Their location within the network is not a factor for deciding trust. Each
user and device on the network require authentication and authorization, based on policy, prior to accessing any applications or resources on the network.
ZTNA  facilitates  security  around  remote  work,  because  Zero  Trust  policies  enable  granular  access  control,  end-to-end  encryption  of  network
communications  and  remove  application  visibility  from  the  public  Internet  which  reduces  the  potential  attack  surface.  Based  on  our  estimates,  using
publicly available market data, we believe that the Zero Trust security market size is projected to grow from $15.6 billion in 2019 to $38.6 billion by 2024,
at a Compound Annual Growth Rate (CAGR) of 19.9% during the forecast period. We believe Zero Trust represents a growing market and an ideal fit for
our technology and products.

With  large  portions  of  the  global  population  now  living  under  some  form  of  lockdown,  the  global  coronavirus  COVID-19  pandemic  has  forced  many
organizations to shift their business processes – and their employees are having to embrace a work-from-home culture on a scale never before attempted.
Remote work has accelerated the adoption of video conferencing and meeting applications across all industries making it an essential tool to connect with
remote customers, workforces, and employees to prevent direct contact. Based on our estimates, using publicly available market data, we believe that the
worldwide video conferencing market size is projected to grow from $14 billion in 2019 to $35 billion by 2026, at a CAGR of 16.5% during the forecast
period.  This  rapid  adoption,  learning  curve  and  demand  to  continue  working  remotely  has  created  significant  security  concerns  and  breaches  for
enterprises. Our market research has focused on security conscious verticals such as healthcare, banking, legal and government where security breaches can
significantly impact outcomes. In many cases, these enterprises adopted industry standard video conferencing tools and are now looking at more secure
alternative solutions. Enterprises want video conferencing solutions that protect their information and allow them greater security control and visibility,
while continuing to be reliable, easy to use and cost effective. Enterprises in these verticals are also looking for video conferencing solutions that integrate
into their existing workflows and better align with specific use cases instead of forcing them to adapt to more one size fits all solutions on the market. We
believe our War Room™ represents a starting point to offer secure video conferencing tools built on a Zero Trust architecture.

Cloud  computing  growth  has  rapidly  expanded  as  enterprises  continue  to  move  applications  and  services  to  the  cloud.  The  cloud  offers  scalability,
operations and development efficiency and remote access benefits for their workforce. Based on our estimates, using publicly available market data, we
believe that the global cloud computing market size is expected to grow from approximately $293 billion in 2020 to over $810 billion by 2026, at a CAGR
of 18.5% during the forecast period. The cloud technology adoption is expected to increase quite significantly in industries where the work-from-home
initiative is helping to sustain enterprise business functions. However, shifting critical data to the cloud has resulted in security concerns and the need for
enterprises  to  control  access  and  gain  visibility  into  how  information  is  being  used,  who  is  accessing  it  and  where  it  is  going.  We  believe  our  scalable
technology allows enterprises to secure applications and services regardless of whether hosting is on-premise or in the cloud.

As billions of connected Internet of Things (“IoT”) devices come online in support of enterprise operations, products, and industrial controls they will need
to be secured and integrated into the enterprise. Facilitated by advancements in 4G/Advanced LTE and high-speed 5G networks, IoT devices will be able to
operate from any network, transmit higher volumes of data including video streaming and sensor data collection and require real-time decisions based on
that data. Without next generation security, these IoT devices represent a large attack surface that manages and control critical enterprise infrastructure.
These IoT devices can operate from anywhere, will need to be secured with the same level of network security and ZTNA solutions enterprises are already
deploying for their remote workforce. We believe that the market opportunity for our software and technology solutions is large and expanding as secure
domain names are now an integral part of securing the next generation 5G and 4G/LTE Advanced wireless networks and IoT communications in areas
including Smart City, Connected Car and Connected Home. Based on our estimates, using publicly available market data, we believe that the size of the
global  Industrial  IoT  market  is  projected  to  grow  from  $83.6  billion  in  2020  to  approximately  $254  billion  by  2027  at  a  CAGR  of  20.35%  during  the
forecasted period with a growing investment in securing the infrastructure around these devices.

Our Approach & Strategy

We believe that our VirnetX One platform and software products, including War Room, are positioned to help enterprises adapt to the rapidly evolving
threat landscape in the work environments and the growing need to secure communications regardless of a user’s location, network, or device using our
GABRIEL Connection Technology™.

VirnetX  One  platform  delivers  ZTNA  allowing  enterprises  to  secure  their  information,  control  access  and  gain  visibility  into  how  information  is  being
used, who is accessing it and where it is going. Our patented technology allows enterprises to license our technology for integration into their products and
services,  easily  deploy  our  technology  through  our  VirnetX  One  family  of  products  for  endpoint  security  or  securing  their  communications  with  our
VirnetX One Mobile and Desktop applications.

Our  strategy  is  to  become  the  market  leader  in  securing  real-time  communications  over  the  Internet  and  to  establish  our  GABRIEL  Connection
Technology™ as the industry standard security platform. Key elements of our strategy are to:

•

Actively  recruit  partners  in  various  vertical  markets,  including  healthcare,  finance,  legal,  government  to  help  us  rapidly  expand  our  enterprise
customer base.

4

 
 
 
 
 
 
 
 
 
Index

•

•

•

Continue  to  grow  our  technology  licensing  program  to  commercialize  our  intellectual  property,  including  our  GABRIEL  Connection
Technology™.

Promote our, next-generation, VirnetX One platform as a solution for delivering ZTNA.

Grow  registration  of  VirnetX  Secure  Domain  Names  as  the  network  segmentation  component  of  our  ZTNA  solution.  Establish  VirnetX  as  the
exclusive, universal registry of secure domain names and enable our customers to act as registrars for their users and broker secure communication
between devices.

• Promote War RoomTM video conferencing product in the general market for sale to end-user enterprises, directly and with partners, with targeted

promotions and other marketing programs to assist remote workers and offer an industry leading secure meeting solution.

•

Grow our VirnetX One family of product offering to secure enterprise applications, services, and infrastructure.

Our  patent  portfolio  serves  as  the  foundation  of  our  GABRIEL  Connection  Technology™,  software  products,  services,  and  our  licensing  business.  We
currently  own  approximately  205  total  patents  and  pending  applications,  including  72  U.S.  patents/patent  applications  and  133  foreign
patents/validations/pending applications. It is expected to generate the majority of our future revenue in license fees and royalties.

Competitive Strengths

We believe the following competitive strengths will enable our success in the marketplace:

•

•

•

Unique patented technology. We are focused on developing innovative technology for securing real-time communications  over  the  Internet  and
establishing the exclusive secure domain name registry in the United States and other key markets around the world. Our unique solutions combine
industry  standard  encryption  methods  and  communication  protocols  with  our  patented  techniques  for  automated  DNS  lookup  mechanisms.  Our
technology  and  patented  approach  enable  users  to  create  a  secure  communication  link  by  generating  secure  domain  names.  We  currently  own
approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending
applications.  Our  portfolio  includes  patents  and  pending  patent  applications  in  the  United  States  and  other  key  markets  that  support  our  secure
domain name registry service for the Internet.

Scalable licensing business model. We are actively engaged in pursuing additional licensing agreements with OEMs, service providers and system
integrators  within  the  IP-telephony,  mobility,  mobile-to-mobile  communications,  fixed-mobile  convergence,  and  unified  communications  end-
markets.

Highly experienced research and development team. Our research and development team is comprised of nationally recognized network security
and  encryption  technology  scientists  and  experts  that  have  worked  together  as  a  team  for  over  ten  years.  During  their  careers,  this  team  has
developed  several  cutting-edge  technologies  for  U.S.  national  defense,  intelligence,  and  civilian  agencies,  many  of  which  remain  critical  to  our
national security today. Prior to joining VirnetX, our team worked for Leidos, during which time they invented the technology that is the foundation
of our technology, and software. Based on the collective knowledge and experience of our development team, we believe that we have one of the
most experienced and sophisticated groups of security experts researching vulnerability and threats to real-time communication over the Internet and
developing solutions to mitigate these problems.

License and Service Offerings

We  offer  a  diversified  portfolio  of  licenses,  software  and  service  offerings  focused  on  securing  real-time  communications  over  the  Internet.  We  believe
software  products  will  allow  enterprises  to  seamlessly  integrate  ZTNA  protection  into  their  networks  to  secure  their  applications,  services,  virtualized
resources, and data as it moves into the cloud. Enterprises can quickly deploy VirnetX One software products to protect legacy applications, secure new
cloud-based  services  and  remove  application  visibility  from  the  public  Internet.  Enterprises  can  move  towards  more  granular  network  access  control  to
protect their network at the edge and away from legacy VPN technologies. VirnetX One family of software products enables remote employees to securely
interact  with  on-premise  and  cloud-based  applications,  regardless  of  their  location.  Enterprises  can  use  VirnetX  One  platform  to  secure  open-source
applications powering communications, data and analytics, infrastructure, and business services with a focus on making those applications easier to secure,
access and manage.

We believe our software products and technologies provide the foundation for securing real-time communications and collaboration applications for the
enterprise remote workforce. We are exploring creating a marketplace of applications secured by our VirnetX One platform. This approach will allow us to
offer  a  portfolio  of  certified  applications  that  can  be  deployed  by  the  enterprise  customers  in  their  business  networks  with  confidence  in  keeping  their
confidential data and communications secure. This marketplace strategy will allow us to offer more flexible licensing options to solve specific customer
use-cases, align with partner product offerings and create upsell opportunities for our products.

5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

Customers

Our software products are available for download and free trial, for Android, iOS, Windows, Linux, and Mac OS X platforms, at http://www.virnetx.com/.
We continue to enhance our products and add new functionality to our products. Small and medium businesses have installed our software products in their
corporate networks. We continue to expand our customer base with targeted promotions and direct sales initiatives.

We have signed Patent License Agreements with Aastra USA, Inc. Avaya, Inc., Microsoft Corporation, Mitel Networks Corporation, NEC Corporation and
NEC Corporation of America, Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc. to license certain of
our patents, for a one-time payment and an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current
and future IP-encrypted products.

We  are  seeking  further  licensing  of  our  technology,  to  developers  and  original  equipment  manufacturers,  or  OEMs,  of  chips,  servers,  Desktop,  mobile
devices  such  as  smart  phones,  tablets,  laptops,  net  books,  and  other  devices,  within  the  IP-telephony,  mobility,  fixed-mobile  convergence,  and  unified
communications markets including 5G and 4G/LTE. We have published our royalty rates and guidelines on our website. All forward moving licenses have
adhered to these guidelines and have met or exceeded these rates and we will use these rates and guidelines in all future license negotiations.

Marketing and Sales

We employ a leveraged, partner-oriented, marketing strategy for our technology licenses and software product offerings. We successfully signed a number
of Resellers & Managed Service Provider Agreements in various market segments, including, healthcare, finance, legal, government, etc., to assist us in
selling our software products to their customers. A list of our partners can be found on our website at https://virnetx.com/partners. We plan to continue
working on a number of sales and marketing promotions, in the U.S. and Japan, to recruit more resellers and partners along with direct sales programs as
we seek to extend out our customer base internationally.

We plan to directly market our software products, domain name registry services to our service provider and system integrator customers. We market our
software products directly to small and medium businesses using online marketing programs and tools.

We  expect  to  leverage  our  relationship  with  Leidos,  to  extend  our  offering  to  departments  and  agencies  within  the  federal  government.  Leidos  is  a
FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance
to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. We intend to leverage our sales team for
managing  current  accounts  and  pursuing  sales  opportunities  with  new  customers.  We  continue  to  rapidly  expand  our  customer  base  with  targeted
promotions and direct sales initiatives.

In 2021, we added a Chief Operating Officer to our Japanese team to further our technology licensing efforts in Japan. We have signed a non-exclusive
Distribution and Service Agreement with IP Dream, a Japanese based strategic technology developer and service provider, to sell our software products as
well as VirnetX’s Secure Domain Name technology to its clients in Japan and greater Asia. Jointly with IP Dream, we are currently pursuing several OEM
opportunities with some of the largest services providers in Japan. Along with our efforts with IP Dream, we continue to explore alternative strategies to
pursue opportunities to work with other third parties in Japan, and elsewhere, using an approach that will seek to capitalize on these opportunities in part by
placing more emphasis on the use of our own employees.

We intend to continue to license our patent portfolio, technology, and software, including our secure domain name registry service, to domain infrastructure
providers, communication service providers as well as to system integrators. We intend to seek further license of our technology and software products, to
enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, Desktop, mobile devices such as smart phones, tablets,
laptops, net books, and other devices, within the IP-telephony, mobility, fixed-mobile convergence, and unified communications markets including 5G and
4G/LTE. We have published our royalty rates and guidelines on our website at https://virnetx.com/licensing. All forward moving licenses have adhered to
these guidelines and have met or exceeded these rates and we will use these rates and guidelines in all future license negotiations.

Intellectual Property and Patent Rights

Our intellectual property is primarily comprised of trade secrets, patented know-how, issued and pending patents, copyrights and technological innovation.

We  currently  own  approximately  205  total  patents  and  pending  applications,  including  72  U.S.  patents/patent  applications  and  133  foreign
patents/validations/pending  applications.  Our  portfolio  includes  many  patents  that  describe  unique  systems  and  methods  for  securing  real-time
communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our software
and technology solutions also may have additional applications relating to operating systems and network security. A complete list of our U.S. patents is
available  on  our  website  located  at  http://www.virnetx.com.  Each  patent  is  publicly  accessible  on  U.S.  Patent  and  Trademark  Office  website  at
http://www.uspto.gov. Some of our issued U.S. and foreign patents expire at various times during the period from 2022 to 2034.

6

 
 
 
 
 
 
 
 
 
 
 
 
 
Index

Notwithstanding anything to the contrary set forth in any of our filings under the Securities Act or the Exchange Act that might incorporate future filings,
the information set forth on the United States Patent and Trademark Office (the “USPTO”) website, shall not be deemed to be a part of or incorporated by
reference into any such filings. We do not warrant the accuracy, or completeness or adequacy of the USPTO website, and expressly disclaims liability for
errors or omissions on such website.

Assignment of Patents

Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, pursuant to an
Assignment Agreement dated December 21, 2006, and a Patent License and Assignment Agreement dated August 12, 2005, as amended on November 2,
2006, including documents prepared pursuant to the November amendment, and as further amended on March 12, 2008. We recorded the assignment from
Leidos, with the U.S. Patent Office on December 21, 2006.

Key terms of these agreements are as follows:

•

•

•

Patent Assignment. Leidos, unconditionally and irrevocably conveyed, transferred, assigned, and quitclaimed all its right, title, and interest in
and to the patents and patent applications, as specifically set forth in the assignment document recorded with the U.S. Patent Office, including,
without limitation, the right to sue for past infringement.

License  to  Leidos,  Outside  the  Field  of  Use.  Effective  March  12,  2008,  we  granted  to  Leidos,  a  non-exclusive,  royalty  free,  fully  paid,
perpetual, worldwide, irrevocable, sub licensable and transferable right and license permitting Leidos, and its assignees to make, have made,
import,  use,  offer  for  sale,  and  sell  products  and  services  covered  by,  and  to  make  improvements  to,  the  patents  and  patent  applications  we
acquired from Leidos, solely outside our field of use.

Compensation Obligations. As consideration for the assignment of the patents and for the rights we obtained from Leidos, as amended, we are
required  to  make  payments  to  Leidos,  based  on  cash  or  certain  other  values  generated  from  those  patents.  The  amount  of  such  payments
depends upon the type of value generated, and certain categories are subject to maximums and other limitations. In 2010, we met our maximum
royalty payment requirement; however, Leidos is also entitled under certain circumstances to receive a portion of the proceeds paid to us for
certain acquisitions of VirnetX and the settlement of certain patent infringement claims of ours.

Government Regulation

The  laws  governing  online  secure  communications  remain  largely  unsettled,  even  in  areas  where  there  has  been  legislative  action.  It  may  take  years  to
determine whether and how existing laws governing intellectual property, privacy, data protection and libel apply to online communications and media.
Such legislation may interfere with the growth in use of online secure communications and decrease the acceptance of online secure communications as a
viable solution, which could adversely affect our business.

Due to the Internet’s popularity and increasing use, new laws regulating secure communications may be adopted. These laws and regulations may cover,
among other things, issues relating to privacy, data protection, pricing, taxation, telecommunications over the Internet, content, copyrights, distribution and
quality of products and services. We intend to comply with all new laws and regulations as they are adopted.

The U.S. government has controlled the authoritative domain name system, or DNS, root server since the inception of the Internet. On July 1, 1997, the
President of the United States directed the U.S. Secretary of Commerce to privatize the management of the domain name system in a manner that increases
competition and facilitates international participation in its management.

On  September  29,  2006,  the  U.S.  Department  of  Commerce  extended  its  delegation  of  authority  by  entering  into  a  new  agreement  with  the  Internet
Corporation for Assigned Names and Numbers, or ICANN, a California non-profit corporation headquartered in Marina Del Rey, California. ICANN is
responsible for managing the accreditation of registry providers and registrars that manage the assignment of top-level domain names associated with the
authoritative DNS root directory. Although it is possible to create and manage other DNS root directories privately without accreditation from ICANN, the
possibility of conflicting name and number assignments makes it less likely that users would widely adopt a top-level domain name associated with an
alternative DNS root directory provided by a non-ICANN-accredited registry service.

Employees and Human Capital

As of December 31, 2021, we had 24 full and part time employees, most of whom work remotely from our corporate offices. We have had a work-from-
home workforce since our inception. The emphasis of our employees is on our technology research and product development with 14 employees focused
on  this  effort.  Our  team  has  been  working  on  enhancing  our  products  and  adding  new  functionality  along  with  successfully  filing  several  new  patent
applications in 2021.  We also continue building our sales and marketing teams to expand our product-lines and customer base. In 2021, we added a Chief
Operating Officer to our team in Japan who will be focused on growing our market and products in that region.

In addition to our regular employees, we also engage with consultants on a regular basis. These consultants can be involved in our product development,
customer  relations,  legal,  and/or  regulatory  compliance  and  reporting.  We  have  experienced  low  employee  turnover  rates  over  the  years  with  both
employees and consultants participating in our equity incentive plan.

7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

Available Information

We file or furnish various reports, such as registration statements, periodic and current reports, proxy statements and other materials with the SEC. Our
website address is http://www.virnetx.com. You may obtain, free of charge on our website, copies of our annual reports on Form 10-K, quarterly reports on
Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as
soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information we post is intended for reference
purposes only; none of the information posted on our website is part of this report or incorporated by reference herein.

The  SEC  also  maintains  website  at  http://www.sec.gov  that  contains  reports,  proxy  and  other  information  statements,  and  other  information  regarding
issuers, including us, that file electronically with the SEC.

Item 1A.

Risk Factors

Our  operations  and  financial  results  are  subject  to  various  risks  and  uncertainties,  including  those  described  below,  which  could  adversely  affect  our
business, financial condition, results of operations, cash flows, and the trading price of our common and capital stock. You should carefully consider the
risks and uncertainties described below in addition to the other information set forth in this Report, including in “Management’s Discussion and Analysis
of  Financial  Condition  and  Results  of  Operations”  and  our  consolidated  financial  statements  and  related  notes,  before  making  any  investment  in  our
common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or
that we currently believe to be immaterial may also adversely affect our business. If any of these risk factors occur, you could lose substantial value or
your entire investment in our shares.

Summary Risk Factors

An investment in our common stock involves a high degree of risk, and the following is a summary of key risk factors when considering an investment.
You should read this summary together with the more detailed description of each risk factor contained in the subheadings further below.

• We are involved and will continue to be involved in litigation defending our patent portfolio, which can be time-consuming and costly, and we

cannot anticipate the results.

• We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

•

•

•

•

•

•

If we are not able to adequately protect our patent rights, our business would be negatively impacted.

Because our business is conducted or expected to be conducted in an environment that is subject to rapid change, we may be subject to various
developments in regulation, law, and consumer preferences to which we may not be able to adapt successfully.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and
Trademark Office, could adversely affect our licensing and enforcement activities and results of operations.

New legislation, regulations or court rulings related to enforcing patents could harm our business and operating results.

Privacy and data security concerns, and data collection and transfer restrictions and related domestic or foreign regulations may limit the use and
adoption of our solutions and adversely affect our business.

If we are unable to expand our revenue sources or establish, sustain, grow, or replace relationships with a diversified customer base, our revenues
may be limited.

• We have limited technical resources and are at an early stage in commercialization of our software products.

•

Our international expansion will subject us to additional costs and risks, and our plans may not be successful.

Risks Related to Our Business and Our Financial Reporting

We are involved and will continue to be involved in litigation defending our patent portfolio, which can be time-consuming and costly, and we cannot
anticipate the results.

We spend a significant amount of our financial and management resources to pursue our current litigation. We believe that this litigation and others that
we may pursue in the future could continue for years and consume significant financial and management resources. The counterparties to our litigation
include large, well-financed companies with substantially greater resources than us. Patent litigation is risky, and the outcome is uncertain, and we cannot
assure you that any of our current or future litigation matters will result in a favorable outcome for us. In addition, even if we obtain favorable interim
rulings or verdicts, they may be inconsistent with the ultimate resolution of the dispute. Furthermore, any awards we receive may be subject to obligations
to Leidos and fee arrangements with outside counsel. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may
be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects,
which could encumber our ability to develop and commercialize our products.

8

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

A large part of our business strategy includes licensing our patents and technology to other companies in order to reach a larger end-user base than we
could reach through direct sales and marketing efforts; as such, our business strategy and revenues may depend on intellectual property licensing fees and
royalties for the majority of our revenues. We currently derive minimal revenue from licensing activities, and royalties, and we cannot assure you that we
will successfully capitalize on our market opportunities or that our current business strategy will succeed.

Although to date we have entered into a limited number of settlement and license agreements, we may not be successful in entering into further licensing
relationships,  or  if  we  are  successful  in  entering  into  such  relationships,  the  acquisition  of  them  may  be  expensive,  and  they,  as  well  as  our  existing
settlement and our existing and pending license agreements may not generate the financial results, we expect.

Factors that may affect our ability to execute our current business strategy include, but are not limited to, the following:

• Third parties may challenge the validity of our patents;

• The pendency of our various litigations may cause potential licensees not to do business with us;

• Our patents may expire before we can make our business strategy successful;

• We face, and we expect to continue to face, intense competition from new and established competitors who may have superior products and

services or better marketing, financial or other capacities than we do; and

•

It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to,
competitive with or superior to ours.

If we are not able to adequately protect our patent rights, our business would be negatively impacted.

We believe our patents are valid, enforceable, and valuable. Notwithstanding this belief, third parties may make claims of infringement or invalidity claims
with respect to our patents and such claims could give rise to material cost for defense or settlement or both, jeopardize or substantially delay a successful
outcome of litigation we are or may become involved in, divert resources away from our other activities, limit or cease our revenues related to such patents,
or  otherwise  materially  and  adversely  affect  our  business.  Similar  challenges  could  also  prevent  us  from  obtaining  additional  patents  in  the  future.
Additionally,  several  of  our  patents  are  currently,  and  other  patents  may  in  the  future  be,  subject  to  USPTO  post-grant  inter  partes  review  proceedings
(“IPR”) which may result in all, or part of these patents being invalidated, or the claims of our patents being limited. Unfavorable or adverse outcomes in
our litigation or IPRs may result in losses, exhaustion of financial resources, reduction in our ability to enforce our intellectual property rights, or other
adverse  effects,  which  could  encumber  our  ability  to  develop  and  commercialize  our  products.  Even  if  we  are  successful  in  enforcing  our  intellectual
property rights, our patents may not ultimately provide us with any competitive advantages and may be less valuable than we currently expect. These risks
may be heightened in countries other than the United States where laws regarding patent protection are less developed, and may be negatively affected by
the fact that legal standards in the United States and elsewhere for protection of intellectual property rights in Internet-related businesses are uncertain and
still evolving. In addition, there are a significant number of United States and foreign patents  and patent applications in our areas of interest, and we expect
that significant litigation in these areas will continue and will add uncertainty to the value of certain patents and other intellectual property rights in our
areas of interest. If we are unable to protect our intellectual property rights or otherwise realize value from them, our business would be negatively affected.

We can provide no assurances that the licensing of our essential security patents under FRAND will be successful.

At the request of the European Telecommunications Standards Institute (“ETSI”), and the Alliance for Telecommunications Industry Solutions (“ATIS”),
we agreed to update our licensing declaration to ETSI and ATIS under their respective Intellectual Property Rights policies. This was in response to our
Statement of Patent Holder identifying a group of our patents and patent applications that we believe are or may become essential to certain developing
specifications in the 3rd Generation Partnership Project Long Term Evolution (“LTE”), Systems Architecture Evolution project. We will make available a
non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms, and conditions, with compensation) for the patents identified by
us  that  are  or  become  essential  to  applicants  desiring  to  implement  the  Technical  Specifications  identified  by  us,  as  set  forth  in  the  updated  licensing
declaration under the ATIS and ETSI Intellectual Property Rights policies. Our licensing declarations under the ATIS and ETSI Intellectual Property Rights
policies may limit our flexibility in determining royalties and license terms for certain of our patents. Consequently, we cannot assure you that the licensing
of the essential security patents will be successful  or that third parties will be willing to enter into licenses with us on reasonable terms or at all, which
could have an adverse effect on our business and harm our competitive position.

9

 
 
 
 
 
 
 
 
 
Index

Because  our  business  is  conducted  or  expected  to  be  conducted  in  an  environment  that  is  subject  to  rapid  change,  we  may  be  subject  to  various
developments in regulation, law, and consumer preferences to which we may not be able to adapt successfully.

The current regulatory environment for our products and services remains unclear. We can give no assurance that our planned product offerings will be in
compliance  with  laws  and  regulations  of  local,  state,  United  States  federal  or  foreign  authorities.  Further,  we  can  give  no  assurance  that  we  will  not
unintentionally violate such laws or regulations or that such laws or regulations will not be modified, or that new laws or regulations will be enacted in the
future which would cause us to be in violation of such laws or regulations. For example, Voice-Over-Internet Protocol (“VoIP”) services are not currently
subject to all the same regulations that apply to traditional telephony, but it is possible that similar regulations may be applied to VoIP in the future and
that these could result in substantial costs to us which could adversely affect the marketability of our products and planned products related to VoIP. For
further example, the use of the Internet and private Internet Protocol (“IP”) networks for communication is largely unregulated within the United States,
but  may  become  regulated  in  the  future;  additionally,  several  foreign  governments  have  enacted  measures  that  could  restrict  or  prohibit  voice
communications services over the Internet or private IP networks.

Our  business  depends  on  the  growth  of  instant  messaging,  VoIP,  mobile  services,  streaming  video,  file  transfer  and  remote  desktop  and  other  next-
generation  Internet-based  applications.  A  decline  in  the  use  of  these  applications  due  to  complexity  or  cost  relative  to  alternate  traditional  or  newly
developed communications channels, or development of alternative technologies, could cause a material decline in the number of users in these areas.

More aggressive domestic or international regulation of the Internet in general, and Internet telephony providers and services specifically may materially
and adversely affect our business, financial condition, operating results, and future prospects.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and Trademark
Office, could adversely affect our licensing and enforcement activities and results of operations.

Our licensing and enforcement activities are subject to numerous risks from outside influences, including the following:

• New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease
our revenue. For instance,  the United States Supreme Court has modified some tests used by the USPTO in granting patents during the past 20
years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or
license.  In  addition,  in  2012  the  United  States  enacted  sweeping  changes  to  the  United  States  patent  system  under  the  Leahy-Smith  America
Invents Act, including changes that transition the United States from a “first-to-invent” system to a “first to file” system and alter the processes for
challenging issued patents;

• More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO;

• Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer; and

• As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

10

 
 
 
 
 
Index

New legislation, regulations or court rulings related to enforcing patents could harm our business and operating results.

Intellectual property is the subject of intense scrutiny by the courts, legislatures, and executive branches of governments around the world. Various patent
offices, governments or intergovernmental bodies may implement new legislation, regulations or rulings that impact the patent enforcement process, or
the rights of patent holders and such changes could negatively affect licensing efforts and/or litigations. For example, limitations on the ability to bring
patent enforcement claims, limitations on potential liability for patent infringement, lower evidentiary standards for invalidating patents, increases in the
cost to resolve patent disputes and other similar developments could negatively affect our ability to assert our patent or other intellectual property rights.

It is impossible to determine the extent of the impact of any new laws, regulations or initiatives that may be proposed, or whether any of the proposals
will become enacted as laws. Compliance with any new or existing laws or regulations could be difficult and expensive, affect the manner in which we
conduct our business and negatively impact our business, prospects, financial condition, and results of operations.

If we experience security breaches or incidents, we could be exposed to liability and our reputation and business could suffer.

We  expect  to  retain  certain  confidential  and  proprietary  customer  information  in  our  secure  data  centers  and  secure  domain  name  registry,  as  well  as
personal data and other confidential and proprietary information relating to our business. It will be critical to our business strategy that our facilities and
infrastructure  remain  secure  and  are  perceived  by  the  marketplace  to  be  secure.  Our  secure  domain  name  registry  operations  will  also  depend  on  our
ability to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption,
and potentially depend on protection by other registrars in the shared registration system. The secure domain name servers that we will operate will be
critical  hardware  to  our  registry  services  operations.  Therefore,  we  expect  to  have  to  expend  significant  time  and  money  to  maintain  or  increase  the
security  of  our  products,  facilities,  and  infrastructure.  Security  technologies  are  constantly  being  tested  by  computer  professionals,  academics  and
“hackers.” Advances in computer capabilities and   the techniques for attacking security solutions, new discoveries in the field of cryptography or other
events  or  developments  could  result  in  compromises  or  breaches  of  our  security  measures  and  could  make  some  or  all  our  products  obsolete  or
unmarketable. Likewise, if any of our products are found to have significant security vulnerabilities, then we may need to dedicate engineering and other
resources to eliminate the vulnerabilities and to repair or replace products already sold or licensed to our customers. Despite the security measures that 
we and our service providers utilize, our infrastructure and that of our service providers may be vulnerable to physical break-ins, computer viruses, attacks
by hackers, phishing attacks, social engineering, or similar disruptive problems. It is possible that we may have to expend additional financial and other
resources  to  address  such  problems.  The  COVID-19  pandemic  is  increasing  vulnerability  to  cyber-attacks,  as  more  individuals  and  companies  work
online, which increases these risks. As a provider of Internet security software and technology, we may be the target of dedicated efforts by hackers and
other third parties to overcome or defeat our security measures. Any physical or electronic break-in or other security breach or incident or compromise of
the information stored at our secure data centers and domain name registration systems, including any compromise due to human error or employee or
contractor malfeasance, may jeopardize the security of information stored on our premises or in the computer systems and networks of our customers. In
such an event, we could face significant liability and current or potential customers could be reluctant to use our services. Additionally, any such data
security  incident,  or  the  perception  that  one  has  occurred  could  also  result  in  adverse  publicity,  harm  to  our  reputation  and  competitive  position,  and
therefore adversely affect the market’s perception of the security of electronic commerce and communications over IP networks as well as the security or
reliability of our services.

A security breach or other security incident could require a substantial level of financial resources to rectify and otherwise respond to, may be difficult to
identify or address in a timely manner, and could result in claims, investigations, and inquires by private parties or governmental entities that may divert
management’s  attention  and  require  the  expenditure  of  significant  time  and  resources,  and  which  may  cause  us  to  incur  substantial fines, penalties, or
other liability and related legal and other costs. Any actual or perceived security breach or other security incident may also harm our reputation and make
it  more  difficult  or  impossible  for  us  to  successfully  market  to  others.  Any  of  the  foregoing  matters  could  harm  our  operating  results  and  financial
condition.

11

 
 
 
 
 
Index

Privacy and data security concerns, and data collection and transfer restrictions and related domestic or foreign regulations may limit the use and
adoption of our solutions and adversely affect our business.

Personal privacy, information security, and data protection are significant issues in the United States, Europe, and many other jurisdictions where we have
operations or offer our products. The regulatory framework governing the collection, processing, storage and use of confidential and proprietary business
information  and  personal  data  is  rapidly  evolving.  The  United  States  federal  and  various  state  and  foreign  governments  have  adopted  or  proposed
requirements regarding the collection, distribution, use, security and storage of personally identifiable information and other data relating to individuals,
and federal and state consumer protection laws are being applied to enforce regulations related to the online collection, use and dissemination of data.

Further, many foreign countries and governmental bodies, including the European Union (“EU”), where we conduct business, have laws and regulations
concerning  the  collection  and  use  of  personal  data  obtained  from  their  residents  or  by  businesses  operating  within  their  jurisdiction.  These  laws  and
regulations  often  are  more  restrictive  than  those  in  the  United  States.  Laws  and  regulations  in  these  jurisdictions  apply  broadly  to  the  collection,  use,
storage, disclosure, and security of data that identifies or may be used to identify or locate an individual, such as names, email addresses and, in some
jurisdictions, IP addresses.

We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information
security in the United States, the EU, and other jurisdictions. For example, the European Commission adopted a General Data Protection Regulation (the
“GDPR”)  that  became  fully  effective  on  May  25,  2018,  superseding  prior  EU  data  protection  legislation,  imposing  more  stringent  EU  data  protection
requirements, and providing for greater penalties for noncompliance. The United Kingdom has enacted a Data Protection Act and legislation referred to as
the UK GDPR that substantially implements the GDPR. We are evaluating obligations imposed on us by the GDPR and we may be required to incur
substantial expense in order to make significant changes to our product and business operations in connection with obtaining and maintaining compliance
with the GDPR and similar legislation, such as the UK GDPR and UK Data Protection Act, all of which may adversely affect our revenue and product
sales.  Additionally,  California  has  enacted  legislation,  the  California  Consumer  Privacy  Act  (the  “CCPA”)  that,  among  other  things,  requires  covered
companies  to  provide  disclosures  to  California  consumers,  and  afford  such  consumers  abilities  to  opt-out  of  certain  sales  of  personal  information.
Additionally, a new privacy law, the California Privacy Rights Act (the “CPRA”), was approved by California voters in the November 2020 election. The
CPRA significantly modifies the CCPA, creating obligations relating to consumer data which began on January 1, 2022, with implementing regulations
expected on or before July  1,  2022,  and  enforcement  beginning  July  1,  2023.  Additionally,  other  U.S.  states  continue  to  propose,  and  in  certain  cases
adopt, privacy-focused legislation. For example, in March 2021, Virginia enacted the Virginia Consumer Data Protection Act, which becomes effective on
January 1, 2023, and in June 2021, Colorado enacted the Colorado Privacy Act, which takes effect July 1, 2023. We cannot yet fully determine the impact
these or future laws, regulations and standards may have on our business, but they may require us to modify our data processing practices and policies and
to incur substantial costs and expenses in an effort to comply. Privacy, data protection and information security laws and regulations are often subject to
differing interpretations, may be inconsistent among jurisdictions, and may be alleged to be inconsistent with our current or future practices. Additionally,
we may be bound by contractual requirements applicable to our collection, use, processing, and disclosure of various types of data, including personal
data, and may be bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters. These and other requirements
could reduce demand for our products, increase our costs, impair our ability to grow our business, or restrict our ability to store and process data or, in
some  cases,  impact  our  ability  to  offer  our  service  in  some  locations  and  may  subject  us  to  liability.  Any  failure  or  perceived  failure  to  comply  with
applicable  laws,  regulations,  industry  standards,  and  contractual  obligations  may  adversely  affect  our  business.  Further,  in  view  of  new  or  modified
federal, state, or foreign laws and regulations, industry standards, contractual obligations and other legal obligations, or any changes in their interpretation,
we  may  find  it  necessary  or  desirable  to  fundamentally  change  our  business  activities  and  practices  or  to  expend  significant  resources  to  modify  our
product and otherwise adapt to these changes. We may be unable to make such changes and modifications in a commercially reasonable manner or at all,
and our ability to develop new products and features could be limited.

The costs of compliance with and other burdens imposed by laws, regulations and standards may limit the use and adoption of our service and reduce
overall  demand  for  it,  or  lead  to  significant  fines,  penalties,  or  liabilities  for  any  noncompliance.  Privacy,  information  security,  and  data  protection
concerns, whether valid or not valid, may inhibit market adoption of our platform, particularly in certain industries and foreign countries.

12

 
 
 
 
Index

We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.

The sales cycle between initial customer contact and execution of a contract or license agreement with a customer or purchaser of our products can vary
widely. We expect that our sales cycles will be long and unpredictable due to several factors, including but not limited to:

• The need to educate potential customers about our patent rights and our product and service capabilities;

• The impact of the COVID-19 pandemic on our potential customers and their business operations, including their budgetary constraints and

resources devoted to adopting new products.

• Our customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;

• Our customers’ budgetary constraints;

• The timing of our customers’ budget cycles;

• Delays caused by customers’ internal review processes; and

• Long sales cycles that may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.

In  addition,  potential  customers  of  our  products  include  local,  state,  federal  and  foreign  government  authorities.  Sales  to  government  authorities  can  be
extended  and  unpredictable.  Government  authorities  generally  have  complex  budgeting,  purchasing,  and  regulatory  processes  that  govern  their  capital
spending, and their spending is likely to be adversely impacted by economic conditions, including impacts from the COVID-19 pandemic. In addition, in
many instances,  sales  to  government  authorities  may  require  field  trials  and  may  be  delayed  by  the  time  it  takes  for  government  officials  to  evaluate
multiple competing bids, negotiate terms, and award contracts.

For these reasons, the sales cycle associated with our products is subject to a number of significant risks that are beyond our control. Consequently, if our
forecasted customer orders  are not realized or delayed, our revenues and results of operations could be materially and adversely affected.

If we are unable to expand our revenue sources or establish, sustain, grow, or replace relationships with a diversified customer base, our revenues may
be limited.

We  currently  generate  revenue  from  a  limited  number  of  customers  that  have  entered  settlement  and  license  agreements.  Our  software  products  and
services currently generating limited revenue, and it will take time for us to grow our installed user base and generate new customers. Additionally, there
is no guarantee that we will be able to derive revenue from new customers, sustain or increase revenue from existing customers or replace customers from
whom we currently generate revenue. As a result, our revenue may be limited or static.

We have limited technical resources and are at an early stage in commercialization of our VirnetX One platform and software products.

Part of our business includes the internal development of commercial products we seek to monetize. This aspect of our business may require significant
capital, time and resources and we cannot guarantee that it will be successful or meet our expectations. As such, we have a small technical team, which
may  limit  our  ability  to  rapidly  adapt  our  product  to  customer  requirements  or  add  new  product  features  to  maintain  our  competitive  edge  and drive
adoption.  Based  on  the  scale  of  our  technical  resources,  our  limited  historical  financial  data  upon  which  to  base  our  projected  revenue  or  planned
operating expenses related to our software products and services, we may not be able to effectively:

• Generate revenues or profit from product sales;

• Drive adoption of our products;

• Attract and retain customers for our products;

13

 
 
 
 
 
 
 
 
 
 
Index

• Provide appropriate levels of customer training and support for our products;

•

Implement an effective marketing strategy to promote awareness of our products;

• Focus our research and development efforts in areas that generate returns on our efforts;

• Anticipate and adapt to changes in our market; or

• Protect our products from any system failures or other breaches.

In addition, a high percentage of our expenses are and will continue to be fixed. Accordingly, if we do not generate revenue as and when anticipated, our
losses may be greater than expected and our operating results will suffer.

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.

Our products are highly technical and complex and, when deployed, may contain errors or defects. Despite testing, some errors in our products may only
be discovered after a product has been installed and used by customers. Any errors or defects discovered in our products after commercial release could
result in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost,
any of which could adversely affect our business, operating results, and financial condition. In addition, we could face claims for product liability, tort, or
breach  of  warranty,  including  claims  relating  to  changes  to  our  products  made  by  our  channel  partners.  The  performance  of  our  products  could  have
unforeseen or unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our
services, which could result in legal claims against us, harming our business. Furthermore, we expect to provide implementation, consulting, and other
technical services in connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated
software, computing, and communications systems. We expect that our contracts with customers will contain provisions relating to warranty disclaimers
and  liability  limitations,  which  may  not  be  upheld.  Defending  a  lawsuit,  regardless  of  its  merit,  is  costly  and  may  divert  management’s  attention  and
adversely  affect  the  market’s  perception  of  us  and  our  products.  In  addition,  if  our  business  liability  insurance  coverage  proves  inadequate  or  future
coverage is unavailable on acceptable terms or at all, our business, operating results, and financial condition could be adversely impacted.

Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks that we cannot control.

Our business will depend upon, among other things, the capacity, reliability, security, and unimpeded access of the infrastructure owned by third parties that
we will use to deploy our offerings. We have no control over the operation, quality, or maintenance of a significant portion of that infrastructure or whether
those third parties will upgrade or improve their equipment. We depend on these companies to maintain the operational integrity of our connections. If one
or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted.
Also, to the extent that the number of users of networks utilizing our current or future products suddenly increases, the technology platform and secure
hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions. System
interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the
networks to users. In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures.
These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to
attract and retain licensees, strategic partners, and customers.

System failure or interruption or our failure to meet increasing demands on our systems could harm our business.

The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer
and  communication  networks  that  we  establish.  To  the  extent,  the  number  of  users  of  networks  utilizing  our  future  products  suddenly  increases,  the
technology platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service
interruptions or delays or system failures. Our systems and operations will also be vulnerable to damage or interruption from, among other things:

• Power loss, transmission cable cuts and other telecommunications failures;

• Damage or interruption caused by fire, earthquake, and other natural disasters;

• Computer viruses or software defects; and

• Physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.

14

 
 
 
 
 
 
 
 
 
 
Index

System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated,
could reduce the appeal of the networks to users. These types of occurrences could cause users to perceive that our solution does not function properly
and could therefore adversely affect our ability to attract and retain licensees, strategic partners, and customers.

Any  significant  problem  with  our  systems  or  operations  could  result  in  lost  revenue,  customer  dissatisfaction  or  lawsuits  against  us.  A  failure  in  the
operation of our secure domain name registration system could result in the inability of one or more registrars to register and maintain secure domain
names for a period of time. A failure in the operation or update of the master directory that we plan to maintain could result in deletion or discontinuation
of assigned secure domain names for a period of time. The inability of the registrar systems we establish, including our back-office billing and collections
infrastructure, and telecommunications systems to meet the demands of an increasing number of secure domain name requests could result in substantial
degradation in our customer support service and our ability to process registration requests in a timely manner.

Our ability to sell our solutions will be dependent on the quality of our technical support, and our failure to deliver high-quality technical support
services could have a material adverse effect on our sales and results of operations.

If we do not effectively assist our customers in deploying our products, succeed in helping our customers quickly resolve post deployment issues and
provide effective ongoing support, or if potential customers perceive that we may not be able achieve to the foregoing, our ability to sell our products
would  be  adversely  affected,  and  our  reputation  with  current  and  potential  customers  could  be  harmed.  In  addition,  as  we  expand  our  operations
internationally, our technical support team will face additional challenges, including those associated with delivering support, training, and documentation
in languages other than English. Our failure to deliver and maintain high-quality technical support services to our customers could result in customers
choosing to use our competitors’ products and support services instead of ours in the future.

Telephone  carriers  have  petitioned  governmental  agencies  to  enforce  regulatory  tariffs,  which,  if  granted,  would  increase  the  cost  of  online
communication, and such increase in cost may impede the growth of online communication and adversely affect our business.

Use of the Internet has over-burdened existing telecommunications infrastructures, and many high traffic areas have begun to experience interruptions in
service. As a result, certain local telephone carriers have petitioned governmental agencies to enforce regulatory tariffs on IP-telephony traffic that crosses
over  their  traditional  telephone  networks.  If  the  relief  sought  in  these  petitions  is  granted,  the  costs  of  communicating  via  online  could  increase
substantially, potentially adversely affecting the growth in the use of online secure communications. Any of these developments could have an adverse
effect on our business.

Our international expansion will subject us to additional costs and risks, and our plans may not be successful.

We  expect  to  expand  our  presence  internationally  in  Japan  and  elsewhere  through  third  party  arrangements  such  as  international  partnerships,  joint
ventures and potentially establishing international subsidiaries and offices. Our international expansion may present challenges and risks, including those
inherent in international operations, to us and may require significant attention from management. For example, the COVID-19 pandemic has and could
continue to disrupt and slow our international expansion and partnership efforts, as our international partners’ businesses could continue to be disrupted.
We may not be successful in our international partnerships, expansion efforts, and we may incur significant operating expenses in our efforts to expand
internationally.

15

 
 
 
 
 
 
 
Index

The global COVID-19 pandemic may harm our business, financial condition, and results of operations.

In December 2019, a novel coronavirus, COVID-19 was reported in China and in March 2020, the World Health Organization declared it a pandemic.
This contagious disease outbreak and related variants have continued to spread across the globe and impact worldwide economic activity and financial
markets. In light of the uncertain and rapidly evolving situation relating to the spread of COVID-19, we continue to take precautionary measures intended
to minimize the risk of the virus to our employees, our customers, and other third parties with whom we interact. We continue to require all employees to
work remotely and have also suspended all non-essential travel worldwide for our employees. While we have a distributed workforce and our employees
are accustomed to working remotely or working with other remote employees, our workforce is not fully remote. Our employees and consultants travel
frequently  to  establish  and  maintain  relationships  with  one  another,  our  customers  and  prospective  customers,  partners,  and  investors.  Although  we
continue  to  monitor  the  situation  and  may  adjust  our  current  policies  as  more  information  and  public  health  guidance  becomes  available,  temporarily
suspending  travel  and  restricting  the  ability  to  do  business  in  person  could  negatively  affect  our  customer  success  efforts,  sales  and  marketing  efforts,
challenge our ability to enter into customer contracts in a timely manner, slow down our recruiting efforts, or create operational or other challenges, any of
which could harm our business, financial condition and results of operations. Furthermore, if a natural disaster, power outage, connectivity issue, or other
event occurred that impacted our employees’ ability to work remotely, it may be difficult or, in certain cases, not possible, for us to continue our business
for a substantial period of time. The increase in remote working may also result in consumer privacy, IT security and fraud concerns as well as increase
our exposure to potential wage and hour issues. In addition, the COVID-19 pandemic may disrupt the operations of our customers, partners, suppliers, and
other third-party providers for an indefinite period of time, including as a result of travel restrictions, adverse effects on budget planning processes, and/or
business shutdowns, all of which could negatively impact our business, financial condition, and results of operations. More generally, despite continued
actions taken by governments and businesses to attempt to contain and treat the disease, and related variants, including the distribution and administration
of  effective  vaccines,  the  COVID-19  pandemic  could  continue  to  adversely  affect  economies  and  financial  markets  globally,  potentially  leading  to  an
economic downturn, which could decrease technology spending and adversely affect our business.

We do not regularly pay dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their
investments.

Our dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition,
results of operations, capital requirements, and investment opportunities. We therefore cannot make assurances that our Board of Directors will determine
to pay regular or special dividends in the future. Accordingly, unless our Board of Directors determines to pay dividends, stockholders will be required to
look to appreciation of our common stock to realize a gain on their investment, which may not occur.

The exercise of our outstanding stock options, warrants, and RSUs and issuance of new shares would result in a dilution of our current stockholders’
voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of
our stock.

The  exercise  of  our  outstanding  vested  stock  options,  warrants,  and  RSUs  would  dilute  the  ownership  interests  of  our  existing  stockholders.  As  of
December  31,  2021,  we  had  outstanding  options,  warrants  and  RSUs  to  purchase  an  aggregate  of  6,931,592  shares  of  common  stock  representing
approximately 9.7% of our total shares outstanding of which 4,938,709 were vested and therefore exercisable. To the extent outstanding stock options are
exercised,  additional  shares  of  common  stock  will  be  issued,  existing  stockholders’  percentage  voting  interests  will  decline  and  the  number  of  shares
eligible for resale in the public market will increase. Such increase may have a negative effect on the value or market trading price of our common stock.

Because ownership of our common stock is concentrated, investors may have limited influence on stockholder decisions.

As of December 31, 2021, our executive officers and directors beneficially owned approximately 14% of our outstanding common stock. In addition, a
group of stockholders that, as of December 31, 2007, held 4,766,666 shares, or approximately 7% of our outstanding common stock, have entered into a
voting agreement with us that requires them to vote all of their shares of our voting stock in favor of the director nominees approved by our Board of
Directors at each director election going forward, and in a manner that is proportional to the votes cast by all other voting shares as to any other matters
submitted to the stockholders for a vote. However, we cannot be certain how many shares of our common stock this group of stockholders currently owns.
Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that
are  contrary  to  your  interests.  This  ability  to  exercise  significant  influence  could  prevent  or  significantly  delay  another  company  from  acquiring  or
merging with us.

16

 
 
 
 
 
 
 
Index

Our protective provisions in our amended and restated certificate of incorporation and bylaws could make it difficult for a third party to successfully
acquire us even if you would like to sell your stock to them.

We have a number of protective provisions in our amended and restated certificate of incorporation and bylaws that could delay, discourage, or prevent a
third party from acquiring control of us without the approval of our Board of Directors. These protective provisions include:

• A  staggered  Board  of  Directors:  This  means  that  only  one  or  two  directors  (since  we  have  a  five-person  Board  of  Directors)  will  be  up  for
election at any given annual meeting. This has the effect of delaying the ability of stockholders to affect a change in control of us because it would
take two annual meetings to effectively replace a majority of the Board of Directors.

• Blank  check  preferred  stock:  Our  Board  of  Directors  has  the  authority  to  establish  the  rights,  preferences,  and  privileges  of  our  10,000,000
authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences
over your shares of our common stock in a manner that is materially dilutive to you. In addition, blank check preferred stock can be used to create
a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of
Directors. We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without
stockholder approval.

• Advance  notice  requirements  for  director  nominations  and  for  new  business  to  be  brought  up  at  stockholder  meetings:  Stockholders
wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows
and in very specific form in order to have the matter voted on at a stockholder meeting. This has the effect of giving our Board of Directors and
management  more  time  to  react  to  stockholder  proposals  generally  and  could  also  have  the  effect  of  disregarding  a  stockholder  proposal  or
deferring it to a subsequent meeting to the extent such proposal is not raised properly.

• No stockholder actions by written consent: No stockholder or group of stockholders may take actions rapidly and without prior notice to our
Board of Directors and management or to the minority stockholders. Along with the advance notice requirements described above, this provision
also gives our Board of Directors and management more time to react to proposed stockholder actions.

• Super majority requirement for stockholder amendments to the bylaws: Stockholder proposals to alter or amend our bylaws or to adopt new

bylaws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.

• No ability of stockholders to call a special meeting of the stockholders: Only the Board of Directors or management can call special meetings
of the stockholders. This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may
need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.

In  addition,  the  provisions  of  Section  203  of  the  Delaware  General  Corporation  Law  govern  us.  These  provisions  may  prohibit  large  stockholders,
particularly those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.

These  and  other  provisions  in  our  amended  and  restated  certificate  of  incorporation,  our  bylaws  and  under  Delaware  law  could  discourage  potential
takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being
lower than it would be without these provisions.

Our amended and restated bylaws designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all
disputes  between  us  and  our  stockholders,  which  could  limit  our  stockholders’  ability  to  choose  the  judicial  forum  for  disputes  with  us  or  our
directors, officers, or employees.

Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (1)
any derivative action or proceeding brought on our behalf, (2) any action asserting a claim of breach of a fiduciary duty owed by any of our directors,
stockholders, officers, or other employees to us or our stockholders, (3) any action arising pursuant to any provision of the Delaware General Corporation
Law, or our amended and restated certificate of incorporation or amended and restated bylaws or (4) any other action asserting a claim that is governed by
the internal affairs doctrine shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State
court in Delaware or the federal district court for the District of Delaware), in all cases subject to the court having jurisdiction over indispensable parties
named as defendants.

17

 
 
 
 
 
 
 
 
 
 
 
Index

However,  notwithstanding  the  exclusive  forum  provisions,  our  amended  and  restated  bylaws  explicitly  state  that  they  would  not  preclude  the  filing  of
claims brought to enforce any liability or duty created under federal securities laws, including the Securities Act or the Exchange Act.

Any  person  or  entity  purchasing  or  otherwise  acquiring  any  interest  in  any  of  our  securities  shall  be  deemed  to  have  notice  of  and  consented  to  this
provision. This exclusive-forum provision may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with us or our
directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find
this  exclusive-forum  provision  in  our  amended  and  restated  bylaws  to  be  inapplicable  or  unenforceable  in  an  action,  we  may  incur  additional  costs
associated with resolving the dispute in other jurisdictions, which could harm our results of operations.

General Risk Factors

We may need to raise additional capital to support our business growth, and this capital may be dilutive, may cause our stock price to drop or may not
be available on acceptable terms, if at all.

We may need to raise additional capital, which may not be available to us when needed or may not be available on terms acceptable to us, to support our
business  growth  or  to  respond  to  business  opportunities,  challenges,  or  unforeseen  circumstances,  including  sales  under  our  past  and  any  future  shelf
registration statements. Our ability to obtain additional capital, if and when required, will depend on our business plans, investor demand, our operating
performance, the condition of the capital markets, the terms of our current contractual obligations and other factors.

If we raise additional funds through the issuance of equity, equity-linked or debt securities, including those under our past and any future shelf registration
statements,  those  securities  may  have  rights,  preferences,  or  privileges  senior  to  the  rights  of  our  common  stock,  and  our  existing  stockholders  may
experience  dilution.  Additionally,  we  are  unable  to  predict  the  future  success  of  any  future  offerings.  Sales  of  a  substantial  number  of  shares  of  our
common stock in the public market, or the perception that these sales or other financings might occur, could depress the market price of our common
stock, and could also impair our ability to raise capital through the sale of additional equity securities. If we issue debt securities or incur indebtedness, we
could  experience  increased  future  payment  obligations  and  a  need  to  comply  with  restrictive  covenants,  such  as  limitations  on  our  ability  to  incur
additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact
our ability to conduct our business. If we are unable to obtain additional capital or are unable to obtain additional capital on satisfactory terms, our ability
to continue to support our business growth or to respond to business opportunities, challenges, or other circumstances could be adversely affected, and our
business may be harmed.

The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our
strategic plan and materially harm our business.

Our success largely depends on the skills, experience, and performance of our key personnel. Due to the specialized nature of our business and limited
staff, we are particularly dependent on Kendall Larsen, our Chief Executive Officer and President. We have no employment agreements with any of our
key executives that prevent them from leaving us at any time. In addition, we do not maintain key person life insurance for any of our officers or key
employees. The loss of Mr. Larsen, or our failure to retain other key personnel or adequately plan for the succession of key personnel, would jeopardize
our ability to execute our strategic plan and materially harm our business.

We will need to recruit and retain additional qualified personnel to successfully grow our business.

Our future success will depend, in part, on our ability to attract and retain qualified engineering, operations, marketing, sales and executive personnel.
Inability to attract and retain such personnel could adversely affect our business. Competition for engineering, operations, marketing, sales, and executive
personnel  is  intense,  particularly  in  the  technology  and  Internet  sectors  and  in  the  regions  where  we  conduct  our  business.  We  may  need  to  invest
significant amounts of cash and equity to attract and retain employees and expend significant time and resources to identify, recruit, train and integrate
such employees, and we may never realize returns on these investments. Additionally, we can provide no assurance that we will attract or retain such
personnel.

18

 
 
 
 
 
 
Index

We have incurred and will continue to incur significant costs as a result of operating as a public company, and our management will be required to
continue to devote substantial time to various compliance initiatives.

The Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as well as other rules implemented by the
SEC  and  the  New  York  Stock  Exchange  (“NYSE”),  impose  various  requirements  on  public  companies,  including  requiring  changes  in  corporate
governance practices. These and proposed corporate governance laws and regulations under consideration may further increase our compliance costs. If
compliance  with  these  various  legal  and  regulatory  requirements  diverts  our  management’s  attention  from  other  business  concerns,  it  could  have  a
material adverse effect on our business, financial condition, and operating results. The Sarbanes-Oxley Act requires, among other things, that we assess
the effectiveness of our internal control over financial reporting annually and disclosure controls and procedures quarterly. If we are unable to assert in
any future reporting periods that our internal control over financial reporting is effective (or if our independent registered public accounting firm is unable
to express an opinion on the effectiveness of our internal controls), we could lose investor confidence in the accuracy and completeness of our financial
reports, which would have an adverse effect on our share price.

Although we believe that we currently maintain effective control over our disclosures and procedures and internal control over financial reporting, we
may in the future identify deficiencies regarding the design and effectiveness of our system of internal control over financial reporting. If we experience
any  material  weaknesses  in  our  internal  control  over  financial  reporting  in  the  future  or  are  unable  to  provide  unqualified  management  or  attestation
reports about our internal controls, we may be unable to meet financial and other reporting deadlines and may incur costs associated with remediation, and
any of which could cause our share price to decline. Moreover, if we identify deficiencies in our internal control over financial reporting that are deemed
to be material weaknesses in future periods, the market price of our common stock could decline, and we could be subject to potential delisting by the
NYSE  and  review  by  the  NYSE,  the  SEC,  or  other  regulatory  authorities,  which  would  require  the  expenditure  by  us  of  additional  financial  and
management resources. As a result, our shareholders could lose confidence in our financial reporting, which would harm our business and the market
price of our common stock.

There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with
U.S. GAAP.  Any  changes  in  estimates,  judgments  and  assumptions  could  have  a  material  adverse  effect  on  our  business,  financial  condition,  and
operating results.

The preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) involves making
estimates,  judgments  and  assumptions  that  affect  reported  amounts  of  assets  (including  intangible  assets),  liabilities  and  related  reserves,  revenues,
expenses,  and  income.  Estimates,  judgments,  and  assumptions  are  inherently  subject  to  change  in  the  future,  and  any  such  changes  could  result  in
corresponding changes to the amounts of assets, liabilities, revenues, expenses, and income. Any such changes could have a material adverse effect on our
business, financial condition, and operating results.

Our results of operations and financial condition could be materially affected by the enactment of legislation implementing changes in the U.S. or
foreign taxation of international business activities or the adoption of other tax reform policies.

As we expand the scale of our international business activities, any changes in the U.S. or foreign taxation of such activities may increase our worldwide
effective tax rate and harm our business, results of operations, and financial condition. For example, the current administration has proposed to increase
the U.S. corporate income tax rate, increase U.S. taxation of international business operations, and impose a global minimum tax which has agreement
from,  many  countries,  and  the  Organization  for  Economic  Cooperation  and  Development.  Other  countries  have  recently  proposed  or  recommended
changes to existing tax laws or have enacted new laws that could impact our tax obligations in countries where we do business or cause us to change the
way we operate our business. The impact of future changes to U.S. and foreign tax law on our business is uncertain and could be adverse, and we will
continue   to monitor and assess the impact of any such changes.

19

 
 
 
 
 
 
 
Index

War, terrorism, other acts of violence, or natural or manmade disasters may affect the markets in which we operate, our clients and our service delivery.

Our business may be adversely affected by instability, disruption, or destruction in a geographic region in which we operate, regardless of cause, including
war, terrorism, riot, civil insurrection, or social unrest, and natural or manmade disasters, including famine, flood, fire, earthquake, storm, or pandemic
events and spread of disease, such as the COVID-19 pandemic. Such events may cause our customers to delay their decisions on spending for the services
we provide and give rise to sudden significant changes in regional and global economic conditions and cycles. These events may also pose risks to our
personnel and to physical facilities and operations, which could adversely affect our financial results.

Trading in our common stock is limited and the price of our common shares may be subject to substantial volatility.

Our common stock is currently listed on the NYSE and was previously listed on the NYSE American LLC (formerly the NYSE MKT LLC). Over the
past years, the market price of our common stock has experienced significant fluctuations. Between January 1, 2021, and December 31, 2021, the reported
last adjusted closing price on the NYSE American LLC, and now NYSE, for our common stock ranged between $2.60 and $8.17 per share. The price of
our common stock may continue to be volatile as a result of several factors, some of which are beyond our control. These factors include, but not limited
to, the following:

• Developments or lack thereof in any then-outstanding litigation;

• Quarterly variations in our operating results;

• Large purchases or sales of common stock or derivative transactions related to our stock;

• Actual or anticipated announcements of new products or services by us or competitors;

• General conditions in the markets in which we compete; and

• General social, political, economic, and financial conditions, including the significant volatility in the global financial markets, and impacts from

the COVID-19 pandemic.

In addition, we believe there has been and may continue to be substantial trading in derivatives of our stock, including short selling activity or related
similar activities, which are beyond our control, and which may be beyond the full control of the SEC and Financial Institutions Regulatory Authority or
“FINRA.” While the SEC and FINRA rules prohibit some forms of short selling and other activities that may result in stock price manipulation,  such
activity may nonetheless occur without detection or enforcement. We have held conversations with regulators concerning trading activity in our stock;
however, there can be no assurance that should there be any illegal manipulation in the trading of our stock, it will be detected, prosecuted, or successfully
eradicated. Significant short selling market manipulation could cause our stock trading price to decline, to become more volatile, or both.

The market price of our common stock has been and may continue to be volatile, and you could lose all or part of your investment.

The trading price of our common stock has been volatile since our initial public offering and is likely to continue to be volatile. Factors that could cause
fluctuations in the market price of our common stock include, but are not limited to the following:

• Price and volume fluctuations in the overall stock market from time to time, including fluctuations due to general economic uncertainty or negative

market sentiment;

• Volatility in the market prices and trading volumes of companies in our industry or companies that investors consider comparable;

• Changes in operating performance and stock market valuations of other companies generally, or those in our industry;

• Sales of shares of our common stock by us or our stockholders;

20

 
 
 
 
 
 
 
 
Index

• Failure of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow us, or our failure to meet

these estimates or the expectations of investors;

• The financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;

• Announcements by us or our competitors of new products or services;

• The public’s reaction to our press releases, other public announcements, and filings with the SEC;

• Rumors and market speculation involving us or other companies in our industry;

• Actual or anticipated changes in our results of operations;

• Actual or anticipated developments in our business, our competitors’ businesses, or the competitive landscape generally;

• Litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;

• Announced or completed acquisitions of businesses or technologies by us or our competitors;

• New laws or regulations or new interpretations of existing laws or regulations applicable to our business;

• Changes in accounting standards, policies, guidelines, interpretations, or principles;

• Any significant change in our management; and

• General economic conditions and slow or negative growth of our markets, including any economic downturn from the COVID-19 pandemic.

Further, in recent years the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market
prices of equity securities of many companies.  These  fluctuations  often  have  been  unrelated  or  disproportionate  to  the  operating  performance  of  those
companies. In addition, the stock prices of many technology companies have experienced wide fluctuations that have often been unrelated to the operating
performance  of  those  companies.  These  broad  market  and  industry  fluctuations,  as  well  as  general  economic,  political  and  market  conditions  such  as
recessions, government shutdowns, global pandemics (such as the COVID-19 pandemic), interest rate changes the stability of the EU (including, but not
limited to, effects from the exit of the United Kingdom or international currency fluctuations, may cause the market price of our common stock to decline.
In the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation
has often been instituted against these companies.

We have broad discretion in how we apply our funds, and we may not use these funds effectively, which could affect our results of operations and cause
our stock price to decline.

Our management has broad discretion in the application of our existing cash, cash equivalents and investments and could spend these funds in ways that
do not improve our results of operations or enhance the value of our common stock. Pending their use, we may invest our available funds in a manner that
does not produce income or that loses value. The failure by our management to apply our available funds effectively could result in financial losses that
could cause the price of our common stock to decline and delay the development of our products.

In  addition,  an  entity  that,  among  other  things,  is  or  holds  itself  out  as  being  engaged  primarily,  or  proposes  to  engage  primarily,  in  the  business  of
investing, reinvesting, owning, trading, or holding certain types of securities would be deemed an Investment Company under the Investment Company
Act of 1940 (the “1940 Act”). If we do not manage our investments and business in a manner that meets the requirements for an exemption under the
1940 Act, we may be deemed to be an investment company under the 1940 Act and subject to additional limitations on operating our business including
limitations on the issuance of securities, which may make it difficult for us to raise capital.

21

 
 
 
 
 
 
 
 
 
 
Index

The market price of our common stock may decline because our operating results may not be consistent and may be difficult to predict.

Our reported net income has fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or
similar  factors.  We  had  net  losses  of  $39.6  million  for  the  year  ended  December  31,  2021.  We  had  net  income  of  $280.4  million  for  the  year  ended
December 31, 2020, we had net losses of $19.2 million for the year ended December 31, 2019. As of December 31, 2021, we had accumulated deficits of
$47.6 million. The following include some of the factors that may cause our operating results to fluctuate:

• The outcome of actions to enforce our intellectual property rights currently in progress or that we may undertake in the future, and the timing

thereof;

• The impact of the COVID-19 pandemic on our sales cycle and results;

• The amount and timing of receipt of license fees from potential infringers, licensees, or customers;

• The rate of adoption of our patented technologies;

• The number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including
the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations,
expiration date etc.;

• The success of a licensee in selling products that use our patented technologies; and

• The amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual

property rights.

These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results
difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common
stock.

Item 1B.

Unresolved Staff Comments.

None.

Item 2.

Properties

Our  principal  executive  offices  are  located  at  308  Dorla  Court,  Suite  206,  Zephyr  Cove,  Nevada,  89448.  We  lease  this  property,  which  comprises
approximately 2,090 square feet of office space, from a third party for a term that ends in October 2023. We have no other properties and believe that our
office facility is suitable and appropriately supports our current business needs.

Item 3.

Legal Proceedings

See Note 12 in the notes to our consolidated financial statements.

Item 4.

Mine Safety Disclosure

Not applicable.

PART II

Item 5.

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock currently trades under the symbol “VHC” on the NYSE.

22

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

Holders of Record

As of March 11, 2022, we had 53 stockholders of record. Because many of our shares of common stock are held of record by brokers and other institutions
on behalf of stockholders, we are unable to estimate the total number of beneficial stockholders represented by such record holders.

Dividend Policy

See Note 8 in the notes to our consolidated financial statements.

Securities Authorized for Issuance under Equity Compensation Plan

See Item 12, Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters for information regarding securities
authorized for issuance.

Stock Performance Graph

This performance graph shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference into any filing of VirnetX
Holding Corporation under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The stock
price  performance  reflected  on  this  graph  is  not  necessarily  indicative  of  future  stock  price  performance.  See  the  disclosure  in  part  I,  Item  1A.  “Risk
Factors” for more information regarding the risks in investing in our common stock.

The graph below matches VimetX Holding Corporation’s cumulative 5-year total shareholder return on common stock with the cumulative total returns of
the S&P 500 Index and the RDG Technology Composite Index. The graph tracks the performance of a $100 investment in our common clock and in each
index (wish the reinvestment of all dividends) from December 31, 2016 to December 31, 2021.

VirnetX Holding Corp
S&P 500
RDG Technology Composite

Recent Sales of Unregistered Securities

None.

12/16

100.00
100.00
100.00

12/17

168.18
121.83
137.44

23

12/18

109.09
116.49
141.58

12/19

172.73
153.17
210.04

12/20

267.08
181.35
311.64

12/21

137.78
233.41
400.39

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

Item 6.

[Reserved]

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Company

We are an Internet security software and technology company with patented technology for various types of secure network communications, including 5G
and 4G LTE network security. Our patented Secure Domain Names and GABRIEL Connection Technology™, are the foundation for our new VirnetX One
platform  that  protects  communications  using  Zero  Trust  Network  Access  (“ZTNA”).  Our  technology  generates  secure  connections  on  a  “zero-click”  or
“single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter
any  encryption  information.  Our  portfolio  of  intellectual  property  is  the  foundation  of  our  business  model.  We  currently  own  approximately  205  total
patents  and  pending  applications,  including  72  U.S.  patents/patent  applications  and  133  foreign  patents/validations/pending  applications.  Our  patent
portfolio is primarily focused on securing real-time communications over the Internet, and related services, and is used in all our technology and products,
some of which were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., or Leidos, (f/k/a Science Applications International
Corporation, or SAIC) in 2006.

Our product portfolio includes sophisticated technologies, products and services that are available for sale worldwide. On March 1, 2022, we launched War
Room™ software, the first product on our next-generation, VirnetX One platform. This new platform builds upon our patented Secure Domain Names and
GABRIEL Connection Technology™ to further enhance the security and efficiency of our patented secure communication links. Our VirnetX One platform
is a security-as-a-service platform that protects enterprise applications, services, and infrastructure from cyber-attacks.

Our  new  War  Room™  software  product  provides  an  industry  leading,  safe,  and  secure  video  conferencing  meeting  environment  where  sensitive
communications and data is invisible to those not authorized to view it. War Room™ validates permissions of all the users, and devices requesting access
to any secure meeting room prior to granting access. We believe our War Room™ will be an attractive solution for government agencies  as  well  as  all
professional sectors such as legal, financial, and medical where limiting access to confidential data is a critical requirement.

Our  GABRIEL  Collaboration  Suite™  is  a  set  of  communication  applications  and  tools  that  use  our  GABRIEL  Secure  Communication  Platform™.  It
enables  seamless  and  secure  cross  platform  communications  between  devices  that  are  enrolled  in  our  “VIRNETX  SECURED”  network  and  have  our
software  installed.  Our  GABRIEL  Collaboration  Suite™  is  available  for  download  and  free  trial,  for  Android,  iOS,  Windows,  Linux,  and  Mac  OS  X
platforms, at https://virnetx.com.

We have an ongoing licensing program under which we offer licenses to a portion of our patent portfolio, technology, and software, including our secure
domain  name  registry  service,  to  domain  infrastructure  providers,  communication  service  providers  as  well  as  to  system  integrators.  Our  GABRIEL
Connection  Technology™  License  is  offered  to  original  equipment  manufacturer  (“OEM”)  customers  who  want  to  adopt  the  GABRIEL  Connection
Technology™  as  their  solution  for  establishing  secure  connections  using  secure  domain  names  within  their  products.  We  have  developed  GABRIEL
Connection Technology™ Software Development Kit (“SDK”) to assist with rapid integration of these techniques into existing software implementations.
Customers who want to develop their own implementation of the VirnetX patented techniques for supporting secure domain names, or other techniques
that are covered by our patent portfolio for establishing secure communication links, can purchase a patent license. The number of patents licensed, and
therefore the cost of the patent license to the customer, will depend upon which of the patents are used in a particular product or service. These licenses will
typically include an initial license fee, as well as an ongoing royalty.

We expect to continue to launch new and enhanced security platforms, software products, and services based on our GABRIEL Connection Technology™.
We will provide updates to new and existing customers as they are released to the public. Many small and medium businesses have installed our software
products in their corporate networks. We intend to continue to expand our customer base with targeted promotions and direct sales initiatives.

Our  employees  include  the  core  development  team  behind  our  patent  portfolio,  technology,  and  software.  Some  members  of  this  team  have  worked
together for over twenty years and were on same team that invented and developed this technology while working at Leidos. The team has continued its
research and development work and expanded the set of patents we acquired in 2006 from Leidos, into a larger patent portfolio. This portfolio now serves
as the foundation of our products, services, and our licensing business. It is expected to generate most of our future revenue in license fees and royalties.
We intend to continue our efforts to develop new products and technologies and further strengthen and expand our patent portfolio. We intend to continue
using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to
early licensing targets or asserting our rights for use of our patents.

24

 
 
 
 
 
 
 
 
 
Index

Litigation

We are subject to various legal proceedings, the outcomes of which are inherently uncertain. We record any potential gains related to legal proceedings
only after cash is collected. We record a liability when it is probable that a loss has been incurred and the amount is reasonably estimable, the determination
of which requires significant judgment. Resolution of legal matters in a manner inconsistent with management’s expectations could have a material impact
on our financial condition and operating results. See Note 12 in the notes to our consolidated financial statements for more information.

Commitments and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2023. We recognize rent expense on a straight-line basis over the term
of the lease.

We entered into a service agreement for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for our employees. We incurred
approximately $791, $324,  and  $1,790  in  rental  fees  and  reimbursements  to  the  LLC  in  2021,  2020  and  2019,  respectively.  We  pay  for  the  Company’s
business usage of the aircraft and have no right to purchase. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the
LLC and control the equity interests of the LLC. We entered into a 12-month non-exclusive agreement with the LLC for use of the plane at a rate of $8 per
flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by
either us or the LLC with 30 days’ notice. The agreement renews on an annual basis unless terminated by either party. Neither party has exercised their
termination rights.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of
assets and liabilities and  disclosure  of  contingent  assets  and  liabilities  at  the  date  of  the  financial  statements  and  the  reported  amounts  of  revenues  and
expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which
involve income taxes, fair value of financial instruments and stock-based compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our
reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could
reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from
period  to  period.  Accordingly,  actual  results  could  differ  materially  from  our  estimates.  To  the  extent  that  there  are  material  differences  between  these
estimates  and  actual  results,  our  financial  condition  or  results  of  operations  will  be  affected.  We  base  our  estimates  on  past  experience  and  other
assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates
of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates
with the Audit Committee of our Board of Directors.

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method require the recognition of deferred tax assets and liabilities
for expected future  tax  consequences  of  temporary  differences  that  currently  exist  between  the  tax  basis  and  financial  reporting  basis  of  our  assets  and
liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income
tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred
taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider
whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is
more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is
based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different
taxing  jurisdictions  and  the  expected  timing  of  the  reversals  of  temporary  differences.  We  believe  the  determination  to  record  a  valuation  allowance  to
reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in
the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation
allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all
available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our
deferred  tax  assets  may  be  realized.  If  and  when  we  believe  it  is  more  likely  than  not  that  we  will  recover  our  deferred  tax  assets,  we  will  reverse the
valuation allowance if any, as an income tax benefit in our statements of operations.

25

 
 
 
 
 
 
 
 
 
 
 
 
Index

We account for our uncertain tax positions in accordance with U.S. GAAP. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-
step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is
more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In
step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be
realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit
is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute
of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to
be  sustained.  Evaluation  of  tax  positions,  their  technical  merits,  and  measurements  using  cumulative  probability  are  highly  subjective  management
estimates. Actual results could differ materially from these estimates.

Fair Value

Fair  value  is  the  price  that  would  result  from  an  orderly  transaction  between  market  participants  at  the  measurement  date.  A  fair  value  hierarchy
prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or
indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions
that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.
We  use  valuation  techniques,  primarily  the  income  and  market  approach,  which  maximizes  the  use  of  observable  inputs  and  minimize  the  use  of
unobservable inputs for recurring fair value measurements.

Stock-based Compensation

We  account  for  stock-based  compensation  using  the  fair  value  recognition  method  in  accordance  with  U.S.  GAAP.  We  recognize  these  compensation
costs on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any,
when  they  occur.  In  addition,  we  record  stock-based  compensation  expense  for  awards  granted  to  non-employees  at  fair  value  of  the  consideration
received or the fair value of the equity instruments issued, as they vest, over the performance period. See Note 6 in the notes to our consolidated financial
statements for more information.

Results of Operations (all amounts in this section are expressed in thousands)

Revenue

Revenue

2021

2020

2019

 $

35 

 $

302,636 

 $

85 

Revenue generated in 2021 was $35, compared to $302,636 in 2020 and $85 in 2019. In 2020, we collected a lump sum payment of $454,034 from Apple,
Inc., as a result of a favorable  court  decision  relating  to  a  patent  infringement  case.  The  one-time  payment  included  past  royalties,  damages  for  willful
infringement, interest, court costs and attorneys’ fees. See Note 2 in the notes to our consolidated financial statements for more information.

We recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see “Litigation”). These
revenues relate to payment for use of our patented technology prior to the signing of a license agreement, and royalty payments after the execution of the
license agreements.

Licensing Costs

Licensing costs

2021

2020

2019

 $

(9,083)  $

90,101 

 $

— 

Included in operating expenses for 2020 was $90,101 in licensing costs we incurred in conjunction with the proceeds received in the case regarding Apple,
Inc. discussed above. Accrued licensing costs of $9,083 were reversed in the year ended December 31, 2021, as a result of litigation. See Note 12 in the
notes to our consolidated financial statements for more information.

26

 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
   
   
 
 
 
Index

Research and Development Expenses

Research and Development

2021

2020

2019

 $

5,557 

 $

8,830 

 $

3,845 

Research and development costs include expenses paid to outside development consultants and compensation-related expenses for our engineering staff.
Research and development costs are expensed as incurred.

Our research and development expenses in 2021 were $5,557 compared to $8,830 in 2020 and $3,845 in 2019. The fluctuation in 2021 compared to 2020
and 2019 was primarily due to changes in engineering staff compensation costs.

Selling, General and Administrative Expenses

Selling, General and Administrative 

2021

2020

2019

 $

52,715 

 $

45,812 

 $

15,905 

Selling,  general  and  administrative  expenses  include  compensation  costs  for  management  and  administrative  personnel,  as  well  as  expenses  for  outside
legal, accounting, and consulting services.

Our selling, general and administrative expenses in 2021 were $52,715 compared to $45,812 in 2020 and $15,905 in 2019. The volatility within selling,
general and administrative expenses was primarily due to legal fees related to cases involving the defense of our patents. Legal fees were $41,828, $30,699,
and $5,898 in 2021, 2020 and 2019, respectively and represented approximately 80% of selling, general and administrative expenses for 2021 compared to
67% for 2020 and 37% for 2019.

Gain on Settlement

In 2020, we recorded a gain of $41,271 pursuant to a favorable court ruling in the case regarding Apple, Inc. discussed above. See Note 2 in the notes to
our consolidated financial statements for more information.

Interest and Other Income, net

Interest and Other Income

2021

2020

2019

 $

48 

 $

108,288 

 $

92 

Interest and other income in 2021 was $48 compared to $108,288 in 2020 and $92 in 2019. During 2020 we received interest of $108,221 pursuant to a
favorable court ruling in the case with Apple, Inc. discussed above. See Note 2 in the notes to our consolidated financial statements for more information.

Effective Income Tax Rate

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

United States federal statutory rate
State taxes, net of federal benefit
Valuation allowance
Stock based compensation
R&D Credit
Other
Effective income tax rate

Year Ended
December 31, 2021 

Year Ended
December 31, 2020 

Year Ended
December 31, 2019 

21.00%    
(0.19)%   
— 
(0.02)%   
0.19%    
(1.57)%   
19.41%    

21.00%    
0.17%    
(12.22)%   
(0.01)%   
(0.21)%   
0.06%    
8.79%    

21.00%
1.99%
(21.96)%
— 
1.34%
(0.38)%
1.99%

The Company’s effective tax rate for both 2020 and 2019 was substantially lower than the statutory Federal income tax rate primarily due to the change in
valuation allowance.

Liquidity and Capital Resources

As  of  December  31,  2021,  our  cash  and  cash  equivalents  totaled  $142,018  and  our  short-term  investments  totaled  $27,254  compared  to  $192,908  and
$28,348, respectively, as of December 31, 2020.

We expect that our cash and cash equivalents and short-term investments as of December 31, 2021, will be sufficient to fund our current level of selling,
general and administration costs, including legal expenses and provide related working capital for the foreseeable future. Over the longer term, we expect
to derive the majority of our future revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain
name registry and product sales in the United States and other markets around the world.

Universal Shelf Registration and ATM Offering

On July 30, 2018 we filed a $100,000 universal shelf registration statement on Form S-3 which was declared effective by the SEC on August 16, 2018. We
also entered an at-the-market equity offering sales agreement (“ATM”) with Cowen & Company, LLC on August 31, 2018, under which we were able to
sell shares of our common stock having an aggregate value of up to $50,000.

27

 
 
   
   
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
Index

We used the ATM proceeds for development, marketing of our software products and services, and general corporate purposes, such as working capital,
capital expenditures, other corporate expenses and potential acquisitions of complementary products, technologies, or businesses. As of August 16, 2021,
the universal shelf registration had expired.

We sold zero shares of common stock under the ATM program during 2021. In 2020, we sold 1,049,382 shares of common stock under the ATM program.
The average sales price per common share sold during 2020 was $4.41, and the aggregate proceeds from the sales totaled $4,627 during the period. Sales
commissions, fees and other costs associated with the ATM transactions totaled $139 for 2020. In 2019, we sold 1,860,483 shares under the ATM. The
average  sales  price  per  common  share  during  2019  was  $5.84,  and  the  aggregate  proceeds  from  the  sales  totaled  $10,866  during  the  period.  Sales
commissions, fees and other costs associated with the ATM totaled $327 for 2019.

Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities. By policy, we limit
the amount of credit exposure to any one issuer.

Investments in fixed rate securities carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a
rise in interest rates. Due in part to these factors, our income from investments may decrease in the future.

We considered the historical volatility of short-term interest rates and determined that it was reasonably possible that an adverse change of 100 basis points
could be experienced in the near term but would have an immaterial impact in the fair value of our investments as they will be maturing in fifteen months
or less. 

28

 
 
 
 
Index

Item 8.

Financial Statements and Supplementary Data

Set forth below, are the audited consolidated financial statements for our company accompanied by all reports thereon of Farber Hass Hurley LLP (PCAOB
No. 223)

FINANCIAL STATEMENTS

Financial Statements Index

Report of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm
Consolidated Balance Sheets of VirnetX Holding Corporation as of December 31, 2021 and December 31, 2020
Consolidated Statements of Operations of VirnetX Holding Corporation for the years ended December 31, 2021, December 31, 2020 and,

December 31, 2019

Consolidated Statements of Comprehensive (Loss) Income of VirnetX Holding Corporation for the years ended December 31, 2021,

December 31, 2020, and December 31, 2019

Consolidated Statements of Stockholders’ Equity of VirnetX Holding Corporation for the years ended December 31, 2021, December 31,

2020 and, December 31, 2019

Consolidated Statements of Cash Flows of VirnetX Holding Corporation for the years ended December 31, 2021, December 31, 2020, and

December 31, 2019

Notes to Consolidated Financial Statements of VirnetX Holding Corporation

29

Page

30
32

33

33

34

35
36

 
 
 
 
Index

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of VirnetX Holding Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of VirnetX Holding Corporation (the “Company”) as of December 31, 2021 and  2020, and
the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year
period ended December 31, 2021, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present
fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows
for each of the years in the three-year period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of
America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s
internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control—Integrated Framework (2013) issued
by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), and our report dated March 16, 2022, expressed an unqualified
opinion.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial
statements  based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  PCAOB  and  are  required  to  be  independent  with  respect  to  the
Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance  about  whether  the  financial  statements  are  free  of  material  misstatement,  whether  due  to  error  or  fraud.  Our  audits  included  performing
procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to
those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits
also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The  critical  audit  matter  communicated  below  is  a  matter  arising  from  the  current  period  audit  of  the  financial  statements  that  was  communicated or
required  to  be  communicated  to  the  audit  committee  and  that:  (1)  relate  to  accounts  or  disclosures  that  are  material  to  the  financial  statements  and  (2)
involved  our  especially  challenging,  subjective,  or  complex  judgments.  The  communication  of  the  critical  audit  matter  does  not  alter  in  any  way  our
opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the
critical audit matter or on the accounts or disclosures to which it relates.

30

 
Index

Description of the Matter

Deferred Taxes

As discussed in Notes 2 and 10 to the financial statements, the Company recorded a deferred tax asset, net of a
valuation  allowance  as  of  December  31,  2021.  In  assessing  the  ability  to  realize  the  deferred  tax  assets,
management considers whether it is more likely than not that some portion or all of the deferred tax assets will not
be realized. The valuation allowance is based on management’s estimates of future taxable income and application
of relevant income tax law.

Our determination that valuation of deferred taxes is a critical audit matter results from the significant judgment
by management when assessing the ability to realize the deferred tax assets, particularly as it relates to estimates
of  future  taxable  income.  This  in  turn  led  to  a  high  degree  of  auditor  judgment,  subjectivity,  and  effort  in
performing procedures relating to management’s assessment of the realizability of deferred tax assets, as it relates
to estimates of future taxable income and application of income tax law.

Audit Procedures

Our principal audit procedures related to the Company’s deferred taxes included the following:

-          We evaluated management’s assessment of the realizability of deferred tax assets on a jurisdictional
basis.  This  included  evaluating  estimates  of  future  taxable  income,  evaluating  management’s  application  of
income tax law, and testing the completeness and accuracy of underlying data used in management’s assessment.

-          We evaluated management’s estimates of future taxable income which involved evaluating whether the
estimates  used  by  management  were  reasonable  considering  the  current  and  past  performance of the respective
entity and whether the estimates were consistent with evidence obtained in other areas of the audit.

/s/ Farber Hass Hurley LLP

We have served as the Company’s auditor since 2008.

Chatsworth, California
March 16, 2022

31

 
 
 
 
 
VIRNETX HOLDING CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)

ASSETS

Index

Current assets:

Cash and cash equivalents
Investments available for sale
Accounts receivables
Prepaid income tax
Prepaid expenses and other current assets

Total current assets

Prepaid expenses and other assets
Property and equipment, net
Deferred tax asset
Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable and accrued liabilities
Accrued payroll and related expenses
Accrued licensing costs
Other liabilities, current

Total current liabilities

Other liabilities

Total liabilities

Commitments and contingencies (Note 4)

Stockholders’ equity:

As of
December 31, 2021   

As of
December 31, 2020 

  $

  $

  $

142,018    $
27,254     
17     
—     
203     
169,492     
1,056     
18     
19,278     
189,844    $

338    $
270     
355     
58     
1,021     

46     
1,067     

192,908 
28,348 
8 
2,905 
263 
224,432 
1,301 
11 
9,049 
234,793 

654 
220 
9,438 
44 
10,356 

— 
10,356 

Preferred  stock,  par  value  $0.0001  per  share  Authorized:  10,000,000  shares  at  December  31,  2021  and

December 31, 2020, Issued and outstanding: 0 shares at December 31, 2021 and December 31, 2020

—     

— 

Common stock, par value $0.0001 per share
Authorized: 100,000,000  shares  at  December  31,  2021  and  December  31,  2020,  Issued  and  outstanding:
71,232,856 shares and 71,058,570 shares, at December 31, 2021 and December 31, 2020, respectively

Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss

Total stockholders’ equity

Total liabilities and stockholders’ equity

See accompanying notes to consolidated financial statements.

32

7     
236,445     
(47,607)    
(68)    
188,777     
189,844    $

7 
232,457 
(8,014)
(13)
224,437 
234,793 

  $

 
   
     
 
   
     
 
   
   
   
   
   
   
   
   
   
      
  
   
      
  
   
   
   
   
 
   
      
  
   
   
   
     
 
 
   
      
  
   
      
  
   
   
      
  
   
   
   
   
   
Index

Revenue
Operating expense:
Licensing costs
Research and development
Selling, general and administrative expenses

Total operating expense
(Loss) income from operations

Gain on settlement
Interest and other income, net

(Loss) income before taxes

Income tax benefit (provision)

Net (loss) income
Basic (loss) earnings per share
Diluted (loss) earnings per share
Weighted average shares outstanding basic
Weighted average shares outstanding diluted

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)

Year Ended
December 31, 2021   

Year Ended
December 31, 2020   

 $

35 

 $

302,636 

Year Ended
December 31, 2019 
85 

 $

(9,083)   
5,577 
52,715 
49,209 
(49,174)   
— 
48 
(49,126)   
9,533 
(39,593)  $
(0.56)  $
(0.56)  $

71,159,458 
71,159,458 

90,101 
8,830 
45,812 
144,743 
157,893 
41,271 
108,288 
307,452 
(27,023)   
 $
280,429 
 $
3.96 
 $
3.92 
70,850,311 
71,615,843 

— 
3,845 
15,905 
19,750 
(19,665)
— 
92 
(19,573)
393 
(19,180)
(0.28)
(0.28)
68,564,321 
68,564,321 

 $
 $
 $

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(in thousands)

Net (loss) income
Other comprehensive (loss) income, net of tax:
Change in unrealized (loss) gain on investments, net
Change in foreign currency translation, net
Total other comprehensive (loss) gain, net of tax
Comprehensive (loss) income

See accompanying notes to consolidated financial statements.

Year Ended
December 31, 2021   
 $

(39,593)  $

Year Ended
December 31, 2020   

Year Ended
December 31, 2019 
(19,180)
 $

3 
(3)
— 
(19,180)

 $

280,429 

— 
1 
1 
280,430 

(51)   
(4)   
(55)   
(39,648)  $

 $

33

 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
Index

VirnetX Holding Corporation
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)

Total shareholders’ equity, beginning balances

 $

224,437 

 $

5,628 

 $

9,888 

Year Ended
December 31,
2020

2019

2021

Common stock and additional paid-in capital:

Beginning balances
Common stock issued for cash, net
Common stock issued for options/RSUs, net
Warrants issued for services
Stock-based compensation
Ending balances

Accumulated deficit (retained earnings)

Beginning balances
Net (loss) income
Dividends
Ending balances

Accumulated other comprehensive loss:

Beginning balances
Change in unrealized investment (loss) gain, net
Change in foreign currency translation, net
Ending balances

Total shareholders’ equity, ending balances

Dividends per share

See accompanying notes to consolidated financial statements.

34

232,464 
— 
(196)
— 
4,184 
236,452 

(8,014)
(39,593)
— 
(47,607)

(13)
(51)
(4)
(68)

223,244 
4,488 
690 
104 
3,938 
232,464 

208,324 
10,539 
670 
— 
3,711 
223,244 

(217,602)   
280,429 
(70,841)   
(8,014)   

(198,422)
(19,180)
— 
(217,602)

(14)   
— 
1 
(13)   

(14)
3 
(3)
(14)

 $

 $

188,777 

 $

224,437 

 $

5,628 

— 

 $

1.00 

 $

— 

 
 
 
 
 
 
 
 
   
   
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
Index

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

Cash flows from operating activities:

Net (loss) income
Adjustments to reconcile net (loss) income to
net cash from operating activities:
Depreciation
Stock-based compensation
Amortization of warrants issuance costs
Deferred income taxes
Changes in assets and liabilities:
Prepaid expenses and other current assets
Accounts payable and accrued liabilities
Other liabilities
Accrued payroll and related expenses
Accrued licensing costs
Accounts receivable
Prepaid income taxes
Net cash (used in) provided by operating activities

Cash flows from investing activities:
Purchase of property and equipment
Purchase of investments
Proceeds from sale or maturity of investments
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from exercise of options
Proceeds from sale of common stock
Dividends paid on common stock
Taxes paid on cashless exercise of restricted stock units
Net cash (used in) provided by financing activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Cash paid for income taxes

See accompanying notes to consolidated financial statements.

Year Ended
December 31, 2021   

Year Ended
December 31, 2020   

Year Ended
December 31, 2019 

 $

(39,593)  $

280,429 

 $

(19,180)

4 
4,184 
34 
(10,229)   

271 
(316)   
60 
50 
(9,083)   
(9)   

2,905 
(51,722)   

(11)   
(26,332)   
27,371 
1,028 

— 
— 
— 
(196)   
(196)   
(50,890)   
192,908 
142,018 
2 

 $
 $

5 
3,938 
69 
(9,049)   

419 
(692)   
(193)   
(67)   

9,438 

(3)   
(2,905)   

281,389 

— 
(33,065)   
7,112 
(25,953)   

1,046 
4,488 
(70,841)   
(356)   
(65,663)   
189,773 
3,135 
192,908 
38,977 

 $
 $

7 
3,711 
— 
— 

374 
296 
97 
10 
— 
1 
(396)
(15,080)

(14)
(5,784)
5,192 
(606)

816 
10,539 
— 
(145)
11,210 
(4,476)
7,611 
3,135 
4 

 $
 $

35

 
 
 
   
     
     
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Index

VirnetX Holding Corporation
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands except share, per share and per device amounts)

Note 1 − Formation and Business of the Company

VirnetX  Holding  Corporation,  which  we  refer  to  as  “we”,  “us”,  “our”,  “the  Company”  or  “VirnetX”,  is  engaged  in  the  business  of  commercializing  a
portfolio of patents. We derive revenue from selling our software products and licensing our technology, including GABRIEL Connection Technology™, to
various original equipment manufacturers (“OEMs”), that use our technologies in the development and manufacturing of their own products within the IP-
telephony,  mobility,  fixed-mobile  convergence,  and  unified  communications  markets.  During  2020,  we  had  revenues  from  settlement  of  a  patent
infringement  dispute  whereby  we  received  consideration  for  past  sales  of  licensee  that  utilized  our  technology,  where  there  was  no  prior  patent  license
agreement.

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 205 total patents and pending applications,
including  72  U.S.  patents/patent  applications  and  133  foreign  patents/validations/pending  applications.  Our  patent  portfolio  is  primarily  focused  on
securing  real-time  communications  over  the  Internet,  as  well  as  related  services  such  as  the  establishment  and  maintenance  of  a  secure  domain  name
registry.  Our  patented  methods  also  have  additional  applications  in  the  key  areas  of  device  operating  systems  and  network  security  for  Cloud  services,
M2M communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S and foreign patents and pending
applications relates generally to securing communications over the Internet and such covers all our technology and other products. Some of our issued U.S.
and foreign patents expire at various times during the period from 2021 to 2034.

Note 2 − Summary of Significant Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and  the  reported  amounts  of  revenues  and  expenses  during  the  reported  period.  The  critical  accounting  policies  we  employ  in  the  preparation  of  our
consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based
compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our
reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could
reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from
period  to  period.  Accordingly,  actual  results  could  differ  materially  from  our  estimates.  To  the  extent  that  there  are  material  differences  between  these
estimates  and  actual  results,  our  financial  condition  or  results  of  operations  will  be  affected.  We  base  our  estimates  on  past  experience  and  other
assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates
of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates
with the Audit Committee of our Board of Directors.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly owned subsidiaries. All intercompany balances
and transactions have been eliminated.

Leases

The Company determines if an arrangement is a lease at inception in accordance with Accounting Standards Codification (“ASC”) Topic 842. Operating
lease right-of-use (“ROU”) assets are included in Prepaid expenses, and other assets on the Condensed Consolidated Balance Sheets. ROU assets represent
the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising
from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term.

36

Index

Revenue Recognition

The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue
in accordance with Accounting Standards Codification Topic 606, Revenue from Contracts with Customers. A performance obligation is a promise in a
contract  to  transfer  a  distinct  good  or  service  to  the  customer.  A  contract’s  transaction  price  is  allocated  to  each  distinct  performance  obligation  and
recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with
revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With  the  licensing  of  our  patents,  performance  obligations  are  generally  satisfied  at  a  point  in  time  as  work  is  complete  when  our  patent  rights  are
transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain  contracts  may  require  our  customers  to  enter  into  a  hosting  arrangement  with  us  and  for  these  arrangements,  revenue  is  recognized  over  time,
generally over the life of the servicing contract.

The  Company  actively  monitors  and  enforces  its  intellectual  property  (“IP”)  rights,  including  seeking  appropriate  compensation  from  third  parties  that
utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for
a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each
element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement,
damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally
recorded  as  a  reduction  to  the  reported  expenses.  Elements  identified  as  damages  or  interest  are  generally  recorded  in  other  income  in  the  condensed
consolidated statement of operations. During the year ended December 31, 2020, the Company collected a lump sum payment of $454,034 from Apple,
Inc., because of a favorable court decision relating to a patent infringement case. The court decision identified the following as the basis of the award:
$302,428 for past royalties, $41,271 in damages for willful infringement, $108,221 for interest, and $2,114 in reimbursement for court costs and attorney’s
fees. Elements of the payment were recognized in the Company’s condensed consolidated statement of operations as follows:

Classification of Payment Received in the Company’s Condensed Consolidated Statement of Operations
Year Ended:

Revenue (royalties)
Operating expenses: selling, general and administrative (reimbursed litigation costs)
Other income: gain (willful infringement)
Other income: interest income (pre- and post-judgment interest)
Total cash received

Licensing Costs

  December 31, 2020 
302,428 
  $
2,114 
41,271 
108,221 
454,034 

  $

Included in operating expenses are licensing costs we incurred in conjunction with the proceeds received from Apple Inc., pursuant to a favorable court
decision relating to a patent infringement case.

Contingent Gains

ASC Topic 450-30-25, Contingent Gains, prohibits recognition of contingent gains until realized. Accordingly, we do not record contingent gains ahead of
such realization. Management generally considers any such gains as realized only upon the collection of cash.

Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash
and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.

Investments

Investments  are  classified  as  available-for-sale  and  are  recorded  at  fair  market  value.  Unrealized  gains  and  losses  are  reported  as  other  comprehensive
income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security’s cost basis. We invest
our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less
than two years. By policy, we limit the amount of credit exposure to any one issuer.

37

 
 
   
   
   
Index

Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation, and amortization. Depreciation and amortization are computed using the
accelerated and straight-line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are
charged to expense as incurred.

Concentration of Credit Risk and Other Risks and Uncertainties

Our  cash  and  cash  equivalents  are  primarily  maintained  at  two  major  financial  institutions  in  the  United  States.  Deposits  held  with  these  financial
institutions  may  exceed  the  amount  of  insurance  provided  on  such  deposits.  A  portion  of  those  balances  are  insured  by  the  Federal  Deposit  Insurance
Corporation, or FDIC. In 2021, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the
normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.

Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of
their generally short maturities.

Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which
can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.

Impairment of Long-Lived Assets

We  identify  and  record  impairment  losses  on  long-lived  assets  used  in  operations  when  events  and  changes  in  circumstances  indicate  that  the  carrying
amount  of  an  asset  might  not  be  recoverable,  but  not  less  than  annually.  Recoverability  is  measured  by  comparison  of  the  anticipated  future  net
undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by
the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff.
Research and development costs are expensed as incurred.

Income Taxes

We  account  for  income  taxes  using  the  asset  and  liability  method.  The  asset  and  liability  method  requires  the  recognition  of  deferred  tax  assets  and
liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets
and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the
income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on
deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we
consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is
more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is
based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different
taxing  jurisdictions  and  the  expected  timing  of  the  reversals  of  temporary  differences.  We  believe  the  determination  to  record  a  valuation  allowance  to
reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in
the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation
allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all
available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our
deferred  tax  assets  may  be  realized.  If  and  when  we  believe  it  is  more  likely  than  not  that  we  will  recover  our  deferred  tax  assets,  we will reverse the
valuation allowance as an income tax benefit in our statements of operations.

38

Index

We  account  for  our  uncertain  tax  positions  in  accordance  with  U.S.  GAAP,  which  utilizes  a  two-step  approach  to  evaluate  tax  positions.  Step  one,
recognition,  requires  evaluation  of  the  tax  position  to  determine  if  based  solely  on  technical  merits  it  is  more  likely  than  not  to  be  sustained  upon
examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the
largest  amount  of  benefit,  determined  on  a  cumulative  probability  basis,  which  is  more  likely  than  not  to  be  realized  upon  ultimate  settlement  with  tax
authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period
in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously
recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions,
their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially
from these estimates.

Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs
on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any, when
they occur. In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the
fair value of the equity instruments issued, as they vest, over the performance period (See Note 6 - Stock-Based Compensation).

Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common
shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the
period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had
been issued.

New Accounting Pronouncements

In December  2019,  the  Financial  Accounting  Standards  Board  (“FASB”)  issued  Accounting  Standards  Update  (“ASU”)  2019-12  Income  Taxes  (Topic
740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The
amendments also improve consistent application of and simplify U. S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
The amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. We adopted
this ASU on January 1, 2021 and there was no material impact on our financial position or cash flows as a result.

Note 3 − Property and Equipment

Our major classes of property and equipment were as follows:

Office furniture
Computer equipment
Total
Less accumulated depreciation
Total property and equipment, net

Depreciation expense for 2021, 2020 and 2019 was $4, $5, and $7 respectively.

Note 4 − Commitments, Contingencies and Related Party Transactions

December 31

2021

2020

79    $
92     
171     
(153)    
18    $

79 
81 
160 
(149)
11 

  $

  $

We lease our offices under an operating lease with a third party expiring in October 2023. We recognize rent expense on a straight-line basis over the term
of the lease. Rent expense was $56, for each of the years 2021, 2020 and 2019. Future minimum rents due under the lease total $56 in 2022 and $46 in
2023 when the lease expires.

We entered into a service agreement for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company.
We incurred approximately $791, $324, and $1,790 in rental fees and reimbursements to the LLC during the years 2021, 2020 and 2019, respectively. We
pay for the Company’s usage of the aircraft and have no rights to purchase. Our Chief Executive Officer and Chief Administrative Officer are the managing
partners of the LLC and control the equity interests of the LLC. We entered into a 12-month non-exclusive agreement with the LLC for use of the plane at a
rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be
cancelled  by  either  us  or  the  LLC  with  30  days’  notice.  The  agreement  renews  on  an  annual  basis  unless  terminated  by  either  party.  Neither  party  has
exercised their termination rights.

39

 
 
 
 
 
   
 
   
   
   
Index

Note 5 − Stock Plan

We have an equity incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “2013 Plan”), which
has been approved by our stockholders. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to
such award will again become available for issuance under the 2013 Plan. The 2013 Plan provides for the granting of stock options and restricted stock
units  purchase  rights  (“RSUs”)  to  our  employees  and  consultants.  Stock  options  granted  under  the  2013  Plan  may  be  incentive  stock  options  or
nonqualified stock options. Incentive stock options (“ISOs”) may only be granted to our employees (including officers and directors). Nonqualified stock
options (“NSOs”) and stock purchase rights may be granted to our employees and consultants. The 2013 Plan expires in 2023.

In April 2021, the Board approved an amendment and restatement of the 2013 Plan to, among other things, increase the shares reserved under the Plan by
2,500,000 shares (the “Plan Amendment”). Our stockholders approved the Plan Amendment at the 2021 Annual Meeting of the Stockholders held on June
3, 2021. The 2013 Plan generally provides for the granting of shares of our common stock, including stock options and RSUs. Options may be granted
under  the  2013  Plan  with  an  exercise  price  determined  by  our  Board  of  Directors,  or  a  duly  appointed  committee  thereof,  provided,  however,  that  the
exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISOs or 85% of
the fair market value at the date of grant in the case of an NSO. The exercise price of an ISO or NSO granted to one of our Named Executive Officers shall
not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less
than 110% of the fair market value of the shares on the date of grant. Stock options granted under the 2013 Plan typically vest over four years and have a
10-year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically
vest over four years. As of December 31, 2021, there were 2,240,296 shares available for grant under the 2013 Plan.

Note 6 − Stock-Based Compensation

The following tables summarize information about stock options and RSUs outstanding at December 31, 2021:

Options Outstanding

Range of
Exercise Prices

$ 2.88 -  6.95 
$ 14.52 - 35.25 

Number

Outstanding    

5,533,812     
863,625     
6,397,437     

Weighted
Average
Remaining
Contractual
Life (Years)    

Weighted
Average
Exercise
Price

Options Vested and Exercisable
Weighted
Average
Remaining
Contractual
Life (Years)    

Weighted
Average
Exercise
Price

Number

Exercisable    

6.66    $
1.31    $
5.94    $

4.50     
22.95     
6.99     

4,050,084     
863,625     
4,913,709     

5.82    $
1.32    $
5.03    $

4.34 
22.95 
7.61 

The following tables summarize activity under the Plan for the indicated periods:

Outstanding at December 31, 2018
Options granted
Options exercised
Options cancelled
Outstanding at December 31, 2019
Options granted
Options exercised
Options cancelled
Outstanding at December 31, 2020
Options granted
Options exercised
Options cancelled
Outstanding at December 31, 2021
Options exercisable at December 31, 2021

Options

Weighted
Average
Exercise
Price

Weighted
Average
Remaining
Contractual
Life (Years)    

Aggregate
Intrinsic
Value

7.72 
6.06 
1.23 
4.95 
8.49 
6.07 
3.99 
5.30 
8.55 
4.43 
— 
22.54 
6.99 
7.61 

— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
5.94 
5.03 

 $

 $

 $

 $
 $

— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
6 
6 

Number of
Shares

5,998,837 
345,000 
(663,816)
(50,000)
5,630,021 
747,500 
(262,031)
(302,969)
5,812,521 
999,500 
— 
(414,584)
6,397,437 
4,913,709 

 $

 $

 $

 $
 $

40

   
 
 
   
 
   
   
 
   
 
 
 
 
   
   
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Index

Outstanding at December 31, 2018
RSUs granted
RSUs vested
RSUs cancelled
Outstanding at December 31, 2019
RSUs granted
RSUs vested
RSUs cancelled
Outstanding at December 31, 2020
RSUs granted
RSUs vested
RSUs cancelled

Outstanding at December 31, 2021

RSUs
Weighted
Average
Grant Date
Fair Value    

Aggregate
Intrinsic
Value

Number of
RSUs

 $

 $

 $

504,994 
229,996 
(207,334)
(29,167)
498,489 
218,329 
(212,495)
— 
504,323 
236,661 
(215,165)
(16,664)

 $

 $

 $

3.83 
6.06 
4.07 
4.65 
4.71 
6.89 
4.63 
— 
5.69 
4.61 
5.23 
5.45 

509,155 

 $

5.38 

 $

— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 

— 

Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2021, which was $2.60 and
the  exercise  price  of  the  options.  For  options  exercised,  the  intrinsic  value  is  the  difference  between  market  price  and  the  exercise  price  on  the  date  of
exercise. In 2021, no options were exercised. In 2020 and 2019, we received cash proceeds of $1,046 and $816 from stock options exercised, respectively.
The total intrinsic value of options exercised was $151 and $2,473 in 2020 and 2019, respectively.

Stock-based compensation expense is included in operating expense for each period as follows:

Stock-Based Compensation by Type of Award
Stock options
RSUs
Total stock-based compensation expense

Year Ended
December 31, 2021   
 $

Year Ended
December 31, 2020   
 $

3,067 
1,117 
4,184 

 $

 $

Year Ended
December 31, 2019 
2,756 
 $
955 
3,711 

 $ 

2,872 
1,066 
3,938 

As  of  December  31,  2021,  there  was  $5,403  of  unrecognized  stock-based  compensation  expense  related  to  unvested  stock  options  and  $2,098  of
unrecognized stock-based compensation expense related to unvested RSUs. These costs are expected to be recognized over a weighted-average period of
2.86 and 2.37 years, respectively.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average
assumptions:

Expected stock price volatility
Risk-free interest rate
Expected life term
Expected dividends

Year Ended
December 31, 2021 

Year Ended
December 31, 2020 

Year Ended
December 31, 2019 

90.58%   
1.06%   

93.45%   
0.63%   

92.34%
2.09%

6.22 years 

6.21 years 

6.14 years 

0%   

0%   

0%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $3.32, $4.62 and $4.63
per share during 2021, 2020 and 2019, respectively.

The expected  life  was  determined  using  the  simplified  method  outlined  in  ASC  718,  “Compensation - Stock Compensation”.  Expected  volatility  of  the
stock options was based upon historical data and other relevant factors.

Note 7 − Earnings Per Share

Basic  earnings  per  share  are  based  on  the  weighted  average  number  of  shares  outstanding  for  a  period.  Diluted  earnings  per  share  are  based  upon  the
weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock
options and RSUs under our stock plan and warrants. During 2021 and 2019, we incurred losses; therefore, the effect of any common stock equivalent
would be anti-dilutive during the years.

41

 
 
 
 
   
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
 
 
 
  
  
 
 
  
  
Index

The table below sets forth the basic and diluted loss per share calculations:

Net (loss) income

Basic weighted average number of shares outstanding
Effect of dilutive securities
Diluted weighted average number of shares outstanding

Basic (loss) earnings per share
Diluted (loss) earnings per share

Note 8 − Common Stock

       Year Ended December 31,
2020

2021

2019

 $

(39,593)

 $

280,429 

 $

(19,180)

71,159 
— 
71,159 

70,850 
766 
71,616 

 $
 $

(0.56)
(0.56)

 $
 $

3.96 
3.92 

 $
 $

68,564 
— 
68,564 

(0.28)
(0.28)

Each share of common stock has the right to one vote. The holders of common stock are entitled to receive dividends whenever funds are legally available
and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends.
Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $0.0001 par value common stock.

On  July  30,  2018  we  filed  a  $100,000  universal  shelf  registration  statement  on  SEC  Form  S-3.  This  replacement  registration  statement  was  declared
effective by the SEC on August 16, 2018. We also entered a new ATM with Cowen on August 31, 2018, under which we could offer and sell shares of our
common stock having an aggregate value of up to $50,000.

We  use  the  ATM  proceeds  for  development  and  marketing  of  our  software  product  and  services,  and  general  corporate  purposes,  which  may  include
working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies, or businesses. As of August 16,
2021, the universal shelf registration expired.

We sold zero shares of common stock under the ATM program during 2021. In 2020, we sold 1,049,382 shares of common stock under the ATM program.
The average sales price per common share sold during the year ended December 31, 2020 was $4.41 and the aggregate proceeds from the sales totaled
$4,627 during the period. Sales commissions, fees and other costs associated with the ATM transactions totaled $139 for 2020. In 2019, we sold 1,860,483
shares under the ATM. The average sales priced during the year ended December 31, 2019 per common share was $5.84 and the aggregate proceeds from
the sales totaled $10,866 during the period. Sales commissions, fees and other costs associated with the ATM totaled $327.

Dividends

On May 8, 2020, we declared a one-time cash dividend to shareholders of record as of the close of business on May 18, 2020 of $1 per share of common
stock, payable on May 26, 2020. The timing and amounts of future dividends, if any, will depend on market conditions, corporate business and financial
considerations and regulatory requirements.

Warrants

In 2020, we issued warrants for the purchase of 25,000 shares of common stock at an exercise price of $5.75 per share, exercisable on the date of grant
expiring in April 2025. The weighted average fair value at the grant date was $4.16 per warrant. The fair value at the grant date was estimated utilizing the
Black-Scholes valuation model with the following weighted average assumptions (i) dividend yield on our common stock of 0 percent (ii) expected stock
price volatility of 97 percent (iii) a risk-free interest rate of 0.27 percent and (iv) and expected option term of 5 years.

Warrants
Issued

Exercise
 Price

25,000 

$5.75 

Outstanding and
Exercisable
December 31, 2020  
25,000 

Issued

Exercised

Terminated /
Cancelled

— 

— 

— 

Outstanding and
Exercisable

December 31, 2021   Expiration Date
April 30, 2025

25,000 

In April 2020, 25,000 warrants with an exercise price of $7.00 per share expired.

Note 9 − Employee Benefit Plan

We  sponsor  a  defined  contribution  401k  plan  covering  substantially  all  our  employees.  Our  matching  contribution  to  the  plan  was  approximately  $145,
$112, and $101 in 2021, 2020 and 2019, respectively.

42

 
 
 
 
   
 
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
 
 
 
 
 
Index

Note 10 − Income Taxes

The income tax provision (benefit) is comprised of the following:

Current:
Federal
State
Foreign

Deferred:
Federal
State

Total income tax (benefit) provision

Year Ended
December 31, 2021   

Year Ended
December 31, 2020 

Year Ended
December 31, 2019 

 $

 $

 $

661 
35 
— 
696 

(10,293)   
64 
(10,229)   

(9,533)  $

 $

35,122 
950 
— 
36,072 

(8,816)   
(233)   
(9,049)   

27,023 

 $

— 
(393)
— 
(393)

— 
— 
— 

(393)

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

United States federal statutory rate
State taxes, net of federal benefit
Valuation allowance
Stock based compensation
R&D Credit
Other
Effective income tax rate

Year Ended
December 31, 2021 

Year Ended
December 31, 2020 

Year Ended
December 31, 2019 

21.00%   
(0.19)%   
— 
(0.02)%   
0.19%   
(1.57)%   
19.41%   

21.00%   
0.17%   
(12.22)%   
(0.01)%   
(0.21)%   
0.06%   
8.79%   

21.00%
1.99%
(21.96)%
— 
1.34%
(0.38)%
1.99%

The Company’s effective tax rate for both 2020 and 2019 was significantly lower than the statutory federal income tax rate primarily due to the change of
valuation allowance. Due to the income in 2020, our valuation allowance against federal net deferred tax assets was fully released in 2020.

Deferred tax assets (liabilities) consist of the following:

Deferred tax assets:
Reserves and accruals
Research and development credits and other credits
Net operating loss carry forward
Stock based compensation
Other
Total deferred tax assets

Valuation allowance
Deferred tax assets after valuation allowance

Total deferred tax liability – depreciation   

As of
December 31, 2021   

As of
December 31, 2020 

 $

 $

 $

 $

58 
92 
9,519 
9,615 
— 
19,284 

— 
19,284 

(6)   

48 
13 
598 
8,998 
3 
9,660 

(611)
9,049 

— 

9,049 

Net deferred tax assets

 $

19,278 

 $

In 2021, 2020 and 2019, we had pre-tax losses of $49,126, pre-tax income of $307,452, and pre-tax losses of $19,573, respectively. At December 31, 2021,
we had federal and state net operating loss carryforwards of approximately $45,326 and $107,989, respectively. However, none of the state net operating
loss  carryover  is  apportioned  to  a  deferred  tax  asset,  because  currently  we  do  not  have  operations  in  the  state  where  losses  accumulated.  The  state  net
operating loss carryforward will be expiring beginning in 2029.

A valuation allowance is provided for deferred tax assets when, in our judgment, based upon currently available information and other factors, it is more
likely than not that all or a portion of such deferred income tax assets will not be realized; management determined no valuation allowance is necessary for
2021.

We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position
will be sustained upon examination. At December 31, 2021,  we have no uncertain tax positions.

43

 
 
   
     
     
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
  
  
  
  
  
  
  
  
 
   
     
 
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
 
  
  
  
  
  
 
  
  
  
  
Index

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to NOLs
and tax credits generated in these years were utilized in 2020. The statute of limitation for these years shall expire three years after the date of filing 2020
income tax returns.

Our  policy  is  to  recognize  interest  and  penalties,  if  any,  accrued  on  any  unrecognized  tax  benefits,  as  a  component  of  income  tax  expense.  We  had  no
interest or penalties accrued for 2021 and 2020.

Note 11 − Fair Value Measurement

Fair  value  is  the  price  that  would  result  from  an  orderly  transaction  between  market  participants  at  the  measurement  date.  A  fair  value  hierarchy
prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or
indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions
that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.
We  use  valuation  techniques,  primarily  the  income  and  market  approach,  which  maximizes  the  use  of  observable  inputs  and  minimize  the  use  of
unobservable inputs for recurring fair value measurements.

Mutual funds: Valued at the quoted net asset value (NAV) of shares held.

U.S. agency and treasury securities: Fair value measured at the closing price reported on the active market on which the individual securities are
traded.

The following table shows the adjusted cost, gross unrealized gains, gross unrealized losses, and fair value of our financial assets as of December 31, 2021
and 2020 (in thousands):

Cash
Level 1:
Mutual funds
U.S. agency securities
U.S. treasury securities

Total

 $

Cash
Level 1:
Mutual funds
U.S. agency securities
U.S. treasury securities

Total

 $

December 31, 2021

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash
and Cash

Equivalents    

Investments
Available
for Sale

 $

35,428 

 $

— 

 $

— 

 $

35,428 

 $

35,428 

 $

— 

106,590 
16,658 
10,646 
133,894 
169,322 

 $

— 
— 
— 
— 
— 

 $

— 
(26)   
(24)   
(50)   
(50)  $

106,590 
16,632 
10,622 
133,844 
169,272 

 $

106,590 
— 
— 
106,590 
142,018 

 $

— 
16,632 
10,622 
27,254 
27,254 

December 31, 2020

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash
and Cash

Equivalents    

Investments
Available
for Sale

 $

121,785 

 $

— 

 $

— 

 $

121,785 

 $

121,785 

 $

— 

70,996 
13,767 
14,707 
99,470 
221,255 

 $

— 
2 
— 
2 
2 

 $

— 
— 
(1)   
(1)   
(1)  $

70,996 
13,769 
14,706 
99,471 
221,256 

 $

70,996 
127 
— 
71,123 
192,908 

 $

— 
13,642 
14,706 
28,348 
28,348 

The maturities of our investments generally range from within one to two years. Actual maturities could differ from contractual maturities due to call or
prepayment provisions.

44

 
 
 
 
   
   
   
   
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
 
 
 
 
   
   
   
   
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
Index

Note 12 – Litigation (all dollar amounts in this section are expressed in thousands except for rates per device)

We have several intellectual property infringement lawsuits pending in the United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

This case began on November 6, 2012, when we had filed a complaint against Apple in United States District Court   (“USDC”) in which we alleged that
Apple infringed on certain of our patents, (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The
accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Post-trial motions
hearing was held on July 18, 2018. On August 31, 2018, the USDC entered a Final Judgment and issued its Memorandum Opinion and Order regarding
post-trial motions, affirming the jury’s verdict of $502,600 and granting VirnetX motions for supplemental damages, a sunset royalty, and the royalty rate
of  $1.20  per  infringing  iPhone,  iPad  and  Mac  products,  pre-judgment  and  post-judgment  interest  and  costs.  Apple  filed  a  notice  of  appeal  with  the
USCAFC in the Apple II case.

On October 9, 2018, USCAFC docketed the appeal as Case No. 19-1050 - VirnetX Inc. v. Apple Inc. On January 24, 2019 Apple filed its opening brief. We
filed our response brief on March 1, 2019. Apple filed its reply brief on April 5, 2019. The oral arguments were heard on October 4, 2019. On November
22, 2019, the USCAFC issued an opinion affirming the district court’s findings that Apple is precluded from making certain invalidity arguments and that
Apple  infringed  the  ’135  and  ’151  patents;  reversing  the  USDC’s  finding  that  Apple  infringed  the  ’504  and  ’211  patents;  and  remanding  the  case  for
proceedings on damages. Apple sought panel and en banc rehearing, which the USCAFC denied on February 10, 2020.

On February 22, 2020, the USDC issued a scheduling order for the parties to brief the court about the need for a new trial for recalculating the damages.
We filed our motion for entry of judgment on February 28, 2020. The arguments on this matter were heard on April 14, 2020. In its order, unsealed on May
1,  2020,  the  USDC  denied  VirnetX’s  motion  for  entry  of  a  new  judgment  based  on  the  prior  jury  verdict  and  ordered  a  new  jury  trial  on  damages. On
August  10,  2020,  the  USDC  granted  Apple’s  motion  for  continuance  and  reset  the  date  to  October  26,  2020.  On  October  30,  2020,  a  jury  returned  a
$502,800 verdict in favor of VirnetX based on Apple’s infringement of two network security patents: VirnetX US Patents No. 6,502,135 and No. 7,490,151.
The  jury  verdict  called  for  damages  of  $0.84  per  accused  device  since  the  2013  launch  of  Apple’s  iOS  7  operating  system  and  represents  598,629,580
infringing units from US sales only. On January 15, 2021, the district court denied Apple’s motion for judgment as a matter of law, and on February 4,
2021, Apple filed a notice of appeal to the USCAFC.

On February 22, 2021, USCAFC docketed the appeal as Case No. 19-1672. Apple’s opening brief was filed on June 2, 2021. VirnetX filed its responsive
brief on July 26, 2021. Apple filed its reply brief on September 13, 2021. The briefing is complete, and we are awaiting the court order with the schedule
for oral arguments in this matter.

VirnetX Inc.  v.  Mangrove  Partners  Master  Fund,  Ltd.,  Apple  Inc.  (USCAFC  Case  20-2271)  and  VirnetX  Inc.  v.  Mangrove  Partners  Master
Fund, Ltd., Apple Inc., and Black Swamp, LLC (USCAFC Case 20-2272)

On September 15, 2020, we filed with the USCAFC an appeal of the invalidity findings by the Patent Trial and Appeal Board (“PTAB”) in inter-partes
review proceedings IPR2015-01046 and IPR2016-00062 involving our U.S. Patent No. 6,502,135, and an appeal of the invalidity findings by the PTAB in
inter partes review proceedings IPR2015-1047, IPR2016- 00063, and IPR2016-00167 involving our U.S. Patent No. 7,490,151. On September 25, 2020,
the USCAFC issued an order consolidating the two appeals. On December 15, 2020, we filed a motion to vacate the PTAB decisions below and to remand
these appeals to the PTAB. On March 16, 2021, the USCAFC denied the motion without prejudice to us raising the challenges made in the motion in our
opening brief. Our opening brief was filed on June 7, 2021.

On June 23, 2021, the USCAFC entered an order directing us (and parties in other appeals that raised Appointments Clause challenges) to file a brief
explaining how they believe their cases should proceed in light of the Supreme Court’s decision in United States v. Arthrex, Inc., 141 S. Ct. 1970 (2021).
On  July  7,  2021,  we  filed  a  brief  in  response  to  the  court’s  order.  Other  parties,  including  the  U.S.  Patent  and  Trademark  Office  (“PTO”)  filed  their
responses  on  July  21,  2021.  On  August  19,  2021,  USCAFC  issued  an  order  remanding  these  appeals  for  the  limited  purpose  of  allowing  VirnetX  the
opportunity to request rehearing of the PTAB’s final written decisions by the Director of the USPTO. The USCAFC retained jurisdiction over the appeals
in  the  meantime.  On  September  20,  2021,  we  filed  our  requests  for  Director  rehearing  with  the  PTO.  On  October  29,  2021,  our  requests  for  Director
rehearing were denied. We subsequently filed an amended opening brief to the USCAFC on December 10, 2021, the other parties filed response briefs on
February  2,  2022,  and  we  filed  a  reply  brief  on  February  22,  2022.  All  the  briefings  have  been  completed.  We  are  awaiting  the  court  order  with  the
schedule for oral arguments in this matter.

45

Index

VirnetX Inc. v. Hirshfeld (USCAFC Case 17-2593, -2594)

On September 22, 2017, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes review proceeding IPR2016-00693
involving  our  U.S.  Patent  No.  7,418,504,  and  an  appeal  of  the  invalidity  findings  by  the  PTAB  in  inter  partes  review  proceeding  IPR2016-00957
involving our U.S. Patent No. 7,921,211. On September 16, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing
VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the PTO. The USCAFC retained jurisdiction over the
appeals in the meantime. On October 18, 2021, we filed our requests for Director rehearing with the PTO. On January 7, 2022, our requests for Director
rehearing were denied. On January 21, 2022, we informed the USCAFC about the denial of Director rehearing and requested that the court dismiss the
appeal involving IPR2016-00957 as moot and vacate the PTAB’s underlying decision. On February 15, 2022, the USCAFC directed the PTO to respond
to our request. The PTO’s response is due on March 8, 2022.

VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 19-1671)

On March 18, 2019, we filed with  the  USCAFC  an  appeal  of  the  invalidity  findings  by  the  PTAB  in  inter-partes  reexamination  proceeding  95/001,679
involving  our  U.S.  Patent  No.  6,502,135.  On  October  5,  2021,  USCAFC  issued  an  order  remanding  these  appeals  for  the  limited  purpose  of  allowing
VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the PTO. The USCAFC retained jurisdiction over the
appeals in the meantime. Our request for Director rehearing with the PTO was filed on November 5, 2021. On January 10, 2022, our request for Director
rehearing was denied. We informed the USCAFC about the denial of Director rehearing and are awaiting the court order with a schedule for briefings in
this matter.

McKool Smith P.C. v. VirnetX, Inc., AAA Case No. 01-20-0003-7975

On March 23, 2020, the law firm of McKool Smith, P.C. (“McKool”) filed a Demand for Arbitration against VirnetX, Inc. with the American Arbitration
Association  (“AAA”).  In  its  demand,  McKool  claimed  that  a  retention  agreement  it  entered  into  in  2010  with  VirnetX  entitled  it  to  a  contingency fee
arising from the recent 2020 payment made in the Apple I case. McKool claimed it was owed approximately $36,300 (or 8% of the Apple I payment). We
filed a general response with the AAA denying McKool’s claim and contested the matter vigorously. An evidentiary hearing was held on the matter during
the week of February 22, 2021 and the parties submitted additional briefings. On April 19, 2021, the arbitrator awarded McKool $36,323 in damages, plus
pre-judgment  interest  in  the  amount  of  5%  simple  interest  from  March  23,  2020  to  April  18,  2021,  and  post-judgment  interest  in  the  amount  of  5%,
compounded annually, until payment of the award. We accrued the resulting $38,284 as of March 31, 2021 and paid that amount to McKool on April 20,
2021. This matter is now closed.

Other Legal Matters

One or more potential intellectual property infringement  claims  may  also  be  available  to  us  against  certain  other  companies  who  have  the  resources  to
defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming,
and  there  is  no  assurance  that  we  could  prevail  on  such  potential  claims  if  we  made  them.  In  addition,  bringing  a  lawsuit  may  lead  to  potential
counterclaims  which  may  distract  our  management  and  our  other  resources,  including  capital  resources,  from  efforts  to  successfully  commercialize  our
products.

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.

Note 13 – Leases

We lease office space under an operating lease which expires on October 31, 2023. At December 31, 2021, the underlying ROU asset and lease liability
totaled $98. At December 31, 2020, the underlying ROU asset and lease liability totaled $44. Lease expense totaled $56 in 2021, 2020 and 2019.

We also lease a facility for corporate promotional and marketing purposes which was prepaid at inception and originally expired in 2024. In September
2020, the lease was extended for one year to 2025, due to COVID use-restrictions. No other terms of the original agreement were affected and there was no
impact on cash flow. At December 31, 2021 and 2020, the ROU asset totaled $948 and $1,248, respectively; lease expense totaled $300, $356 and $385,
during 2021, 2020 and 2019, respectively.

46

Index

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of VirnetX Holding Corporation

Opinion on Internal Control over Financial Reporting

We  have  audited  VirnetX  Holding  Corporation’s  (the  Company’s)  internal  control  over  financial  reporting  as  of  December  31,  2021,  based  on  criteria
established  in  Internal  Control—Integrated  Framework  (2013)  issued  by  the  Committee  of  Sponsoring  Organizations  of  the  Treadway  Commission
(COSO). In our opinion,  the  Company  maintained,  in  all  material  respects,  effective  internal  control  over  financial  reporting  as  of  December  31,  2021,
based on criteria established in Internal Control—Integrated Framework (2013) issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated
balance sheets and the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows of the Company,
and our report dated March 16, 2022, expressed an unqualified opinion.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of
internal  control  over  financial  reporting,  included  in  the  accompanying  Management’s  Report  on  Internal  Control  Over  Financial  Reporting.  Our
responsibility  is  to  express  an  opinion  on  the  Company’s  internal  control  over  financial  reporting  based  on  our  audit.  We  are  a  public  accounting  firm
registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance  about  whether  effective  internal  control  over  financial  reporting  was  maintained  in  all  material  respects.  Our  audit  of  internal  control  over
financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and
testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control
over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation  of  financial  statements  in  accordance  with  generally  accepted  accounting  principles,  and  that  receipts  and  expenditures  of  the  company  are
being  made  only  in  accordance  with  authorizations  of  management  and  directors  of  the  company;  and  (3)  provide  reasonable  assurance  regarding
prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial
statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness  to  future  periods  are  subject  to  the  risk  that  controls  may  become  inadequate  because  of  changes  in  conditions,  or  that  the  degree  of
compliance with the policies or procedures may deteriorate.

/s/ Farber Hass Hurley LLP

Chatsworth, California
March 16, 2022

47

 
 
 
 
 
 
 
 
 
 
 
 
Index

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an
evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the
Securities Exchange Act of 1934, as amended, December 31, 2021.

The  purpose  of  this  evaluation  was  to  determine  whether  as  of  December  31,  2021  our  disclosure  controls  and  procedures  were  effective  to  provide
reasonable assurance  that  the  information  we  are  required  to  disclose  in  our  filings  with  the  SEC,  (i)  is  recorded,  processed,  summarized  and  reported
within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2021, our disclosure controls
and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting (as such term is defined in rules 13a-15(f) under the Securities Exchange Act of
1934, as amended) during the fiscal year ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal
controls over financial reporting.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over
financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with
accounting  principles  generally  accepted  in  the  United  States  of  America.  Internal  control  over  financial  reporting  includes  maintaining  records  that  in
reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of
our  financial  statements;  providing  reasonable  assurance  that  receipts  and  expenditures  of  Company  assets  are  made  in  accordance  with  management
authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on
our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not
intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal  Control  –
Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management
concluded  that  the  Company’s  internal  control  over  financial  reporting  was  effective  as  of  December  31,  2021.  There  were  no  changes  in  our  internal
control over financial reporting during the period ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our
internal control over financial reporting. Farber Hass Hurley LLP has audited our internal control over financial reporting as of December 31, 2021; their
report is included elsewhere herein.

Item 9B.

Other Information

None.

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

None.

48

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

Item 10.

Directors, Executive Officers and Corporate Governance

 PART III

The information required by this item will be contained in our definitive proxy statement to be filed with the SEC in connection with our 2022 Annual
Meeting of Stockholders (the “Proxy Statement”), which is expected to be filed not later than 120 days after the end of our fiscal year ended December 31,
2021 and is incorporated in this report by reference.

Item 11.

Executive Compensation

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Securities Authorized for Issuance Under the Equity Compensation Plans

We have an equity incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “2013 Plan”), which
has been approved by our stockholders. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to
such award will again become available for issuance under the 2013 Plan. The 2013 Plan provides for the granting of stock options and restricted stock
units  purchase  rights  (“RSUs”)  to  our  employees  and  consultants.  Stock  options  granted  under  the  2013  Plan  may  be  incentive  stock  options  or
nonqualified stock options. Incentive stock options (“ISOs”) may only be granted to our employees (including officers and directors). Nonqualified stock
options (“NSOs”) and stock purchase rights may be granted to our employees and consultants. The 2013 Plan expires in 2023. In April 2021, our Board of
Directors approved an amendment and restatement of the 2013 Plan to, among other things, increase the shares reserved under the Plan by 2,500,000 shares
(the “Plan Amendment”). Our stockholders approved the Plan Amendment at the 2021 Annual Meeting of the Stockholders held on June 3, 2021.

As of December 31, 2021, there were 2,240,296 shares available to be granted under the Plan. We had 6,397,437 and 5,812,521 options outstanding as of
December 31, 2021 and December 31, 2020, respectively, with an average exercise price of $6.99 and $8.55, respectively. We had 509,155 and 504,323
RSUs outstanding as of December 31, 2021 and December 31, 2020, respectively, with a weighted average grant price of $5.38 and $5.69, respectively.

Plan Category
Equity compensation plans approved by security holders
Equity compensation plans not approved by security holders
Total

Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options and
RSUs
6,906,592    $
—     
6,906,592    $

Weighted-Average
Exercise Price of
Outstanding
Options and RSUs   

Number of
Securities
Remaining
Available for
Future Issuance
Under Equity
Compensation
Plans

6.88     
—     
6.88     

2,240,296 

2,240,296 

On June 3, 2021, the Compensation Committee of our Board of Directors (the “Compensation Committee”) granted 37,500 stock options and 24,999 RSUs
to  members  of  our  Board  of  Directors.  On  June  14,  2021,  the  Compensation  Committee  granted  742,000  stock  options  and  211,662  RSUs  to  our
employees.  On  August  2,  2021,  the  Compensation  Committee  granted  50,000  stock  options  to  an  employee.  On  September  1,  2021,  the  Compensation
Committee granted 120,000 options to an employee. On December 13, 2021, the Compensation Committee granted 50,000 options to an employee.

Item 13.

Certain Relationships and Related Transactions, and Director Independence

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Item 14.

Principal Accountant Fees and Services

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

49

 
 
 
 
 
 
 
 
 
 
   
 
   
   
  
   
 
 
 
 
 
Index

Item 15.

Exhibits and Financial Statement Schedules

(a)

The following documents are filed as part of this Annual Report on Form 10-K

PART IV

(1)

Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of this Annual Report on Form 10-K.

(2)

(3)

Exhibit
Number
3.1
3.2
4.1

4.2
4.3
4.4
4.5
4.6
10.1
10.2*
10.3*
10.4*
10.5*
10.6*
10.7*

10.8

10.9

10.10

10.11

10.12

10.13**

10.14

10.15

10.16

10.17

10.18**

10.19**

Financial Statement Schedule: Financial statement schedules are omitted because they are not applicable, or the required information is shown
in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are required
or because the required information is given in the financial statements or the notes thereto.

Exhibits: The documents listed in the Exhibit Index of this Annual Report on Form 10-K are incorporated by reference or are filed with this
Annual Report on Form 10-K, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

EXHIBIT INDEX

Description

Certificate of Incorporation of the Company.
Bylaws of the Company.
Form of Warrant Agency Agreement by and between the Company
and Corporate Stock Transfer, Inc. as Warrant Agent.
Form of Series I Warrant.
Specimen Common Stock Certificate.
Form of Senior Indenture.
Form of Subordinated Indenture.
Description of Capital Stock.
Form of Indemnification Agreement.
2007 Stock Plan, as amended.
Amended Form of Stock Option Agreement – 2007 Stock Plan.
Form of Restricted Stock Unit Award Agreement – 2007 Stock Plan.
2013 Equity Incentive Plan, as amended.
Form of Stock Option Agreement – 2013 Equity Incentive Plan.
Form of Restricted Stock Unit Agreement – 2013 Equity Incentive
Plan.
Voting Agreement among the Company and certain of its
stockholders, dated as of December 12, 2007.
Securities Purchase Agreement, dated as of September 2, 2009, by
and between the Company and the Purchasers (as defined therein).
Form of Registration Rights Agreement by and between the
Company and the Purchasers (as defined therein).
Form of Underwriting Agreement between VirnetX Holding
Corporation and Gilford Securities Incorporated.
Patent License and Assignment Agreement by and between the
Company and Leidos, Inc. (formerly Science Applications
International Corporation) dated as of August 12, 2005.
Amendment No. 1 to Patent License and Assignment Agreement by
and between the Company and Leidos, Inc. dated as of November 2,
2006.
Amendment No. 2 to Patent License and Assignment Agreement by
and between VirnetX, Inc. and Leidos, Inc. dated as of March 12,
2008.
Security Agreement by and between the Company and Leidos, Inc.
dated as of August 12, 2005.
Assignment Agreement between the Company and Leidos, Inc.
dated as of December 21, 2006.
Professional Services Agreement by and between the Company and
Leidos, Inc. dated as of August 12, 2005.
Settlement and License Agreement, by and between Microsoft
Corporation and VirnetX, Inc., dated May 14, 2010.
Amended Settlement and License Agreement, by and between
Microsoft Corporation and VirnetX, Inc., dated December 17, 2014.

50

Form
8-K
8-K
S-1/A

8-K
S-3
S-3
S-3
10-K
10-K
10-Q
10-Q
10-Q
DEF 14A
10-K
10-K

10-K

8-K

8-K

S-1/A

8-K

8-K

8-K

8-K

8-K

8-K

10-Q/A

Incorporated by reference herein
Exhibit No.
3.1
3.2
4.1

11/01/2007
11/01/2007
01/16/2009

Filing Date

4.1
4.1
4.2
4.4
4.6
10.1
10.2
4.5
10.3
Appendix A
10.6
10.7

09/03/2009
07/30/2018
07/30/2018
07/30/2018
03/16/2020
03/18/2019
05/10/2012
05/10/2011
05/10/2012
04/13/2021
03/02/2015
03/02/2015

File No.

000-26895
000-26895
333-153645

001-33852
333-226413
333-226413
333-226413
001-33852
001-33852
001-33852
001-33852
001-33852
001-33852
001-33852
001-33852

10.11

03/31/2008

001-33852

10.1

10.2

1.1

10.4

10.6

10.1

10.5

10.7

10.8

10.1

09/03/2009

001-33852

09/03/2009

001-33852

01/16/2009

333-153645

07/12/2007

000-26895

07/12/2007

000-26895

03/18/2008

001-33852

07/12/2007

000-26895

07/12/2007

000-26895

07/12/2007

000-26895

01/31/2011

001-33852

10-K

10.23

03/02/2015

001-33852

 
 
 
 
 
 
 
 
10-Q

10-Q

8-K

10-Q

10.1

10.2

10.1

10.1

11/09/2017

001-33852

11/09/2017

001-33852

08/31/2018

001-33852

11/08/2021

001-33852

Index

10.20**

10.21

10.22

10.23*

23.1

24.1
31.1

31.2

32.1†

32.2†

Amended and Restated Revenue Sharing Agreement by and
between VirnetX Holding Corporation and Public Intelligence
Technology Associates, dated October 18, 2017.
Amended and Restated Gabriel License Agreement by and between
VirnetX Holding Corporation and Public Intelligence Technology
Associates, dated October 18, 2017.
Sales Agreement, dated August 31, 2018, by and between VirnetX
Holding Corporation and Cowen and Company, LLC.
Hire Letter by and between Katherine Allanson and the Company,
dated as of September 1, 2021.
Consent of Farber Hass Hurley LLP, Independent Registered Public
Accounting Firm.
Power of Attorney (contained on signature page hereto)
Chief Executive Officer Certification pursuant to Rule 13a-14(a) of
the Securities Exchange Act.
Chief Financial Officer Certification pursuant to Rule 13a-14(a) of
the Securities Exchange Act.
Chief Executive Officer Certification pursuant to 18 U.S.C. Section
1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
Chief Financial Officer Certification pursuant to 18 U.S.C. Section
1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002.
XBRL Instance Document

101.INS
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (formatted as inline XBRL and
contained in Exhibit 101)

*

Indicates management contract or compensatory plan.

**

Confidential treatment has been granted by the SEC as to certain portions of this exhibit.

*** Portions of this exhibit have been omitted pending a determination by the SEC as to whether these portions should be granted confidential treatment.

†

The certifications attached as Exhibit 32.1 and 32.2 that accompany this Report are not deemed filed with the Securities and Exchange Commission
and are not to be incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act or the Exchange Act, whether
before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

51

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-
K to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 16, 2022

VirnetX Holding Corporation

By: /s/ Kendall Larsen

Name: Kendall Larsen
Title: Chief Executive Officer and President

 
 
 
 
 
 
 
 
 
 
 
 
Index

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kendall Larsen as his attorney-
in-fact, with full power of substitution, for him in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same,
with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that
said attorney-in-fact, or his substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on
behalf of the registrant and in the capacities indicated.

Name

/s/ Kendall Larsen
Kendall Larsen

/s/ Katherine Allanson
Katherine Allanson

/s/ Robert D. Short III
Robert D. Short III

/s/ Gary Feiner
Gary Feiner

/s/ Michael F. Angelo
Michael F. Angelo

/s/ Thomas M. O’Brien
Thomas M. O’Brien

Capacity

Date

  Director, Chief Executive Officer and President

  March 16, 2022

(Principal Executive Officer)

  Chief Financial Officer

(Principal Financial Officer and
Principal Accounting Officer)

  Director

  Director

  Director

  Director

  March 16, 2022

  March 16, 2022

  March 16, 2022

  March 16, 2022

  March 16, 2022

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-149883, 333-196064,
333-218467, and 333-258131) of our reports dated March 16, 2022, relating to the consolidated financial statements of VirnetX
Holding  Corporation  (the  “Company”),  and  the  effectiveness  of  the  Company’s  internal  control  over  financial  reporting,
appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2021.

EXHIBIT 23.1

/s/ Farber Hass Hurley LLP

Chatsworth, California
March 16, 2022

 
 
 
 
 
EXHIBIT 31.1

I, Kendall Larsen, certify that:

CERTIFICATIONS

1.

I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2021;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements  made,  in  light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the  period  covered  by  this
report;

3. Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all  material  respects  the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The  registrant’s  other  certifying  officer  and  I  are  responsible  for  establishing  and  maintaining  disclosure  controls  and  procedures  (as  defined  in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:

(a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our  supervision,  to
ensure  that  material  information  relating  to  the  registrant,  including  its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those
entities, particularly during the period in which this report is being prepared;

(b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

(c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed  in  this  report  any  change  in  the  registrant’s  internal  control  over  financial  reporting  that  occurred  during  the  registrant’s  most  recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably

likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control

over financial reporting.

Date: March 16, 2022

/s/ Kendall Larsen
Kendall Larsen
President and Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 31.2

I, Katherine Allanson, certify that:

CERTIFICATIONS

1.

I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2021;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements  made,  in  light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the  period  covered  by  this
report;

3. Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all  material  respects  the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The  registrant’s  other  certifying  officer  and  I  are  responsible  for  establishing  and  maintaining  disclosure  controls  and  procedures  (as  defined  in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:

(a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our  supervision,  to
ensure  that  material  information  relating  to  the  registrant,  including  its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those
entities, particularly during the period in which this report is being prepared;

(b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

(c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed  in  this  report  any  change  in  the  registrant’s  internal  control  over  financial  reporting  that  occurred  during  the  registrant’s  most  recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably

likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control

over financial reporting.

Date: March 16, 2022

/s/ Katherine Allanson
Katherine Allanson
Chief Financial Officer
(Principal Accounting and Financial Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

EXHIBIT 32.1

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended
December 31, 2021 as filed with the Securities and Exchange Commission on March 16, 2022 (the “Report”), I, Kendall Larsen,
President  and  Chief  Executive  Officer  of  the  Company,  certify,  pursuant  to  18  U.S.C.  Section  1350,  as  adopted  pursuant  to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 16, 2022

/s/ Kendall Larsen
Kendall Larsen
President and Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

EXHIBIT 32.2

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended
December  31,  2021  as  filed  with  the  Securities  and  Exchange  Commission  on  March  16,  2022  (the  “Report”),  I,  Katherine
Allanson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 16, 2022

/s/ Katherine Allanson
Katherine Allanson
Chief Financial Officer
(Principal Accounting and Financial Officer)